OXIDATIVE STRESS AND PROTEOMIC STUDIES OF MAMMALIAN MODELS OF AGE-RELATED METABOLIC DYSFUNCTION IN NEURODEGENERATIVE DISORDERS by Swomley, Aaron M.
University of Kentucky 
UKnowledge 
Theses and Dissertations--Chemistry Chemistry 
2017 
OXIDATIVE STRESS AND PROTEOMIC STUDIES OF MAMMALIAN 
MODELS OF AGE-RELATED METABOLIC DYSFUNCTION IN 
NEURODEGENERATIVE DISORDERS 
Aaron M. Swomley 
University of Kentucky, aaron.swomley@uky.edu 
Digital Object Identifier: https://doi.org/10.13023/ETD.2017.052 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Swomley, Aaron M., "OXIDATIVE STRESS AND PROTEOMIC STUDIES OF MAMMALIAN MODELS OF AGE-
RELATED METABOLIC DYSFUNCTION IN NEURODEGENERATIVE DISORDERS" (2017). Theses and 
Dissertations--Chemistry. 73. 
https://uknowledge.uky.edu/chemistry_etds/73 
This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been 
accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For 
more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my thesis or dissertation and abstract are my original work. Proper attribution 
has been given to all outside sources. I understand that I am solely responsible for obtaining 
any needed copyright permissions. I have obtained needed written permission statement(s) 
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine) which will be 
submitted to UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s thesis including all 
changes required by the advisory committee. The undersigned agree to abide by the statements 
above. 
Aaron M. Swomley, Student 
Dr. D. Allan Butterfield, Major Professor 
Dr. Mark Lovell, Director of Graduate Studies 
 
 
OXIDATIVE STRESS AND PROTEOMIC STUDIES OF MAMMALIAN MODELS 
OF AGE-RELATED METABOLIC DYSFUNCTION IN NEURODEGENERATIVE 
DISORDERS: (1) UPREGULATION OF PIN1 IN ALZHEIMER MOUSE MODEL 
(2) ANALYSIS OF BRAIN POST-INTRANASAL ADMINISTRATION OF INSULIN 
IN ALZHEIMER AND INDUCED DIABETIC MOUSE MODELS (3) ANALYSIS OF 
PROTEOME CHANGES IN THE PARIETAL LOBULE OF RHESUS MONKEY 
NON-HUMAN PRIMATE FOLLOWING RESVERATROL SUPPLEMENTATION 





A dissertation submitted in partial fulfillment of the 
 requirements for the degree of Doctor of Philosophy in the 
College of Arts and Sciences  
at the University of Kentucky 
 
By 
Aaron Michael Swomley 
Lexington, Kentucky 









ABSTRACT OF DISSERTATION 
OXIDATIVE STRESS AND PROTEOMIC STUDIES OF MAMMALIAN MODELS 
OF AGE-RELATED METABOLIC DYSFUNCTION IN NEURODEGENERATIVE 
DISORDERS: (1) UPREGULATION OF PIN1 IN ALZHEIMER MOUSE MODEL 
(2) ANALYSIS OF BRAIN POST-INTRANASAL ADMINISTRATION OF INSULIN 
IN ALZHEIMER AND INDUCED DIABETIC MOUSE MODELS (3) ANALYSIS OF 
PROTEOME CHANGES IN THE PARIETAL LOBULE OF RHESUS MONKEY 
NON-HUMAN PRIMATE FOLLOWING RESVERATROL SUPPLEMENTATION 
AS A PART OF A WESTERN-DIET 
 
Expression proteomics is the field of science wherein proteins that make 
up the cellular proteome are identified both by name and by fold-change. 
Depending on the application of proteomics, this change in level could be due to 
internal cellular stressors or introduction of xenobiotics. Global oxidative stress 
measures use immunohistochemistry to determine the relative level of oxidative 
stress of macromolecules within the cell. In this dissertation, both global oxidative 
stress measures and expression proteomics were used in a variety of 
mammalian models in order to determine the effects of protein upregulation, 
intranasal insulin administration, and resveratrol supplementation on the cellular 
proteome and the resultant oxidative stress that occurs. 
 
Pin1, a phosphorylation specific peptidyl-prolyl (cis/trans) isomerase that 
targets specific effector proteins, has been found to act upon a number of 
important proteins identified as contributing towards the progression and ultimate 
deterioration seen in AD. Pin1 was selected for viral upregulation in AD mouse 
models because of Pin1’s regulatory function in regards to tau-
hyperphosphorylation and amyloid-precursor protein (APP) processing, and the 
fact that it has been shown that Pin1 levels decrease and is oxidatively modified 
in brain as AD progresses. In this dissertation study, expression proteomics was 
employed after viral upregulation of Pin1 in AD mouse models in order to 
observe the changes in protein expression that follow. The findings of this 
dissertation study uncover a number of proteins with differential expression as a 
function of age following upregulation of Pin1 in an AD model providing evidence 
for the possibility of Pin1 being the target of future therapeutics to combat the 
progression of AD. 
 
Insulin, while widely being known for its role in the control of blood glucose 
levels and cellular energetics, has recently become the focus of interest with 
regards to its effect on the brain in neurodegenerative disorders such as AD, 
 
 
though the downstream effects with respect to changes in the proteome and 
oxidative stress levels in AD mouse models remain to be clarified. This 
dissertation study focused upon the administration of insulin via the intranasal 
route using four mouse models including AD (APP/PS1), induced-diabetes 
(dbdb), and the AD/induced-diabetes cross (dbdbxAPP/PS1), and a wildtype 
control in order to study the effect of insulin on the brain of these disease state 
models with regards to oxidative stress and expression proteomics. The 
information garnered from this study suggest a possible beneficial effect, with 
regards to protein carbonyl levels, of intra-nasal insulin administration in the AD 
mouse models and the cross model, while yielding mixed results for most other 
models which may be due to low sample size and internal variability between 
animals. Through the use of expression proteomics and Two-way ANOVA, 
proteins from many different cellular processes were identified with differential 
expression. The results from these dissertation studies shed new light on the 
application of intra-nasal insulin to mitigate the effects of AD, a link that has been 
shown in recent years. 
 
A diet high in saturated fats and simple sugars, also known as a western-
diet, has been implicated in the progression of metabolic disorders, 
cardiovascular disorders, and most recently cognitive disorders. Resveratrol, an 
antioxidant that has gained notoriety in the past decade, has been shown to have 
beneficial effects with regards to some metabolic disorders, provided the subject 
had metabolic disorders to begin with. This dissertation study was focused 
around the supplementation of resveratrol into the diets of non-human primate 
rhesus monkeys when given a high-fat and sugar diet. The parietal lobule was 
selected for examination and expression proteomics employed in order to identify 
proteins representative of a wide range of cellular processes as having 
differential expression. These identified proteins represent possible routes of 
downstream action by resveratrol, as well as display protein level changes simply 
through the ingestion of high-fat and sugar diet alone.  
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CHAPTER 1: INTRODUCTION 
 
The studies reported within this dissertation were performed to achieve a better 
understanding of the relationship between Alzheimer disease (AD) with an 
emphasis on glucose metabolic deficiencies known to contribute to the 
progressive neurodegeneration inherent in this disease. By utilizing oxidative 
stress measurements and proteomics, a better understanding of the biochemical 
relationships between AD and metabolic syndrome has been obtained. 
Furthermore, the identification of key brain protein constituents that contribute to 
the disease progression may lead to the identification of target proteins for future 
therapeutics. 
 
AD and metabolic syndrome, while appearing to be disparate disease states, 
share common themes such as increased oxidative stress, neurodegeneration, 
altered cellular signaling, and glucose metabolic deficiencies (Butterfield, Drake 
et al. 2001, Keeney, Swomley et al. 2012, Barone, Di Domenico et al. 2014, 
Luque-Contreras, Carvajal et al. 2014, Tangvarasittichai 2015). To elucidate 
information about the progression of AD specifically, both transgenic and knock-
in mouse models of AD and metabolic syndrome were obtained and the samples 
probed for oxidative stress measures and expression proteomics. One protein in 
particular that provides regulatory oversight over a large number of cellular 
systems, protein interacting with NIMA-1 (Pin1) of the peptidyl-prolyl cis/trans 
isomerase (PPIase) class, was specifically upregulated in the AD mouse brain, 
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and changes to the global brain oxidative stress and brain proteome were 
analyzed. 
Intranasal insulin has been the focus of increasing interest due to the finding that 
the intranasal route of administration allows insulin access to the brain without 
the need to invasively transverse the blood brain barrier (BBB) while also 
preventing peripheral insulin-induced blood glucose loss (Henkin 2010). This 
finding, coupled with the finding that intranasal insulin has been shown to 
improve cognition in humans and rodents, led us to examine the potential 
proteomic implications to the treatment (Benedict, Hallschmid et al. 2007). To 
study the relationship between metabolic syndrome and AD, a mouse model was 
obtained in which diabetes was induced. This mouse was then crossed with an 
AD mouse model to provide a novel AD/db mouse to aid in our investigations. 
Insulin was administered via the intranasal route over a two-month window and 
the mice were harvested. The samples then underwent oxidative stress 
measures and proteomics, yielding insights into the means by which insulin may 
work as a therapeutic in AD. 
While intranasal insulin administration has been shown to be effective in the 
treatment of AD, the prevention of the pathology and subsequent clinical 
presentation is of utmost importance. The Western-diet (a diet rich in saturated 
fat and refined sugar; HFS diet) has been demonstrated to lead to not only 
diabetic complications, but also neurodegeneration and a decline in cognitive 
function (Myles 2014). Resveratrol (RSV) is a poly-phenolic compound with 
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potential as a therapeutic supplement and has had some success in the 
prevention of oxidative stress and treatment of some clinical presentations 
associated with neurodegeneration and metabolic syndrome (Bastianetto, 
Menard et al. 2015, Szkudelski and Szkudelska 2015). In order to study this link, 
brain samples from non-human primates fed an HFS diet were compared to 
those fed an HFS diet supplemented with resveratrol emphasizing proteomic 
analysis. The results of this project have yielded insights into the potential 
proteome changes that resveratrol may induce which provide cellular protection 
from damage that accompanies an HFS diet. 
 
In summary, the following hypotheses were addressed in this dissertation 
research: 
1) Up-regulation of Pin1 in AD mouse models upregulates protective 
enzymes and provides protection from oxidative stress. 
2) Intranasal insulin administration in AD and obese mouse models 
ameliorates oxidative stress and upregulates protective enzymes. 
3) Resveratrol supplementation leads to the upregulation of protective 
enzymes in brain of Rhesus monkeys raised on high fat and sugar diets 





CHAPTER 2: BACKGROUND 
 
2.1 ALZHEIMER DISEASE OVERVIEW 
Alzheimer disease (AD) is a neurodegenerative disease that affects a large and 
ever growing population of Americans 65 years of age or older, a number that 
current estimates place at approximately 5.1 million and which may grow to over 
20 million by the year 2050 due to an aging Baby Boomer population (Hebert, 
Scherr et al. 2003). Classically, AD has been linked to a loss of synapses, an 
increase in the number of extracellular β-amyloid plaques formed from the 
amyloidogenic processing of amyloid precursor protein (APP), as well as an 
increase in intracellular neurofibrillary tangles (NFTs) composed of aggregated 
hyperphosphorylated Tau, a microtubule stabilizing protein (Katzman and Saitoh 
1991). In the last decade or so, strong evidence has emerged linking AD to an 
increase in oxidative stress due in part to both the increased production of 
reactive oxygen and nitrogen species (ROS and RNS respectively) as well as a 
loss of function of many antioxidant defense enzymes (Butterfield 1997, 
Markesbery 1997, Aksenov, Tucker et al. 1998, Munch, Schinzel et al. 1998, 
Butterfield, Howard et al. 1999, Koppal, Drake et al. 1999, Markesbery and 
Carney 1999, Varadarajan, Yatin et al. 1999, Butterfield and Kanski 2002, 




2.1.1 ALZHEIMER DISEASE STAGING 
AD is clinically characterized by a decline in episodic memory that is often 
mistaken for normal cognitive deficiencies due to aging. Because the pathology 
remains hidden within the patient’s brain tissue, clinical diagnosis during the 
earlier stages of the disease is a process that remains inherently error-prone and 
subjective, though advances have been made in which to aid a physician in 
making a correct diagnosis (Waldemar, Phung et al. 2007, Mattila, Koikkalainen 
et al. 2011). A diagnosis of AD is established using the guidelines set by the 
National Institute of Neurological and Communicative Disorders and Stroke and 
the AD and Related Disorders Association (NINCDS-ADRDA). Using these 
guidelines, both possible as well as probable AD are diagnosed using cognitive 
exams and neuroimaging methods that attempt to differentiate between normal 
aging, patients with non-AD dementia, and AD. To date, physicians have access 
to an array of tools designed to help with diagnosis such as the Mini Mental State 
Evaluation (MMSE), which is used to track a patients cognitive prowess (a 30 
point scale is used with greater than 25 being normal and less than 25 as 
probable AD), and also imaging alternatives such as MRI and PET scans that 
help visualize both the potential hippocampal, sulci, and gyri degeneration as 
well as glucose utilization (Folstein, Folstein et al. 1975, de Leon, George et al. 
1983, Jack, Petersen et al. 1999, Sultana and Butterfield 2010). More recently 
much research has been conducted in search for a viable blood or cerebral 
spinal fluid (CSF) biomarker that would allow for early non-subjective detection 
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(Aluise, Sowell et al. 2008, Trojanowski, Vandeerstichele et al. 2010, Sultana, 
Mecocci et al. 2011). 
Typical AD can be classified into four main stages: Pre-clinical AD (PCAD), mild 
cognitive impairment (MCI; most often amnestic MCI or aMCI), early-AD (EAD) 
and late-stage AD (LAD). PCAD is defined as the stage of AD in which the 
patient presents as a fully cognitive, non-AD patient on cognitive instruments 
such as MMSE, yet the growing pathology within the brain tissue is present yet 
likely unknown precluding early death from a non-neurodegenerative means 
(Small, Fratiglioni et al. 2001, Sperling, Aisen et al. 2011). aMCI has been 
described as being the transition stage between normal cognition and EAD, and 
is able to be subdivided into both aMCI  and non-amnestic-MCI, the former of the 
two presenting with memory deficits and demonstrates a 10-15% conversion rate 
per year to AD (Petersen 2000, Petersen 2004, Sultana and Butterfield 2010). 
Pathologically, each stage differs in that both amyloid plaques as well as NFTs 
increase in distribution and density from MCI to LAD, though non-demented 
individuals also are known to possess both types of pathology while maintaining 
normal cognition (Tremblay, Pilote et al. 2007). Through use of imaging 
techniques such as MRI, all three stages of clinical AD described demonstrate 
varying degrees of degeneration, with MCI presenting only a small amount of 
degeneration affecting the hippocampus, sulci, and gyri whereas a much larger 
degree of neurodegeneration affecting the same brain regions in LAD as well as 
an additional atrophy of the frontal lobe and ventricular widening is observed in 
EAD and LAD (Drayer, Heyman et al. 1985, Jack, Petersen et al. 1999, Farrow, 
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Thiyagesh et al. 2007). Additionally, research conducted using positron-emission 
tomography (PET) scans concluded that regional glucose utilization within the 
brain, including the temporal lobe, was significantly reduced in AD patients, a 
trend that was shown to remain true for possible PCAD and MCI patients, 
indicating a severe energy deficiency as glucose is known to be the predominant 
source of energy for brain tissue (de Leon, George et al. 1983, Herholz, Salmon 
et al. 2002, Chetelat, Desgranges et al. 2003, Chetelat, Eustache et al. 2005, 
Petrie, Cross et al. 2009).  
The employment of redox proteomics has given substance to these claims as our 
laboratory has shown that vital glycolytic enzymes have become oxidatively 
modified with a reduced activity that may account for or at least contribute to a 
loss of metabolic activity as observed by PET scans (Castegna, Aksenov et al. 
2002, Butterfield, Galvan et al. 2010). 
2.1.2 AMYLOID BETA AND OXIDATIVE STRESS 
AD is histopathologically characterized by the presence of abnormal protein 
deposits, including senile plaques (rich in amyloid β-peptide [Aβ]) and 
neurofibrillary  tangles (NFT, rich in hyperphosphoryalted tau) (Selkoe 2001), and 
synaptic loss. Structural MRI studies demonstrate early brain atrophy in AD that 
is predominant in hippocampus, precuneus, temporal and parietal lobes, parts 
of the frontal cortex and cingulate gyrus. In contrast, the cerebellum typically 
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displays minor, if any, changes in AD brain compared to controls (Fox, Crum et 
al. 2001).  
A number of hypotheses have been proposed to link the pathologic lesions, 
neuronal histopathology, biochemistry, and clinical symptoms of AD, including 
the amyloid cascade, excitotoxicity, oxidative stress, and inflammation 
hypotheses. All these hypotheses are based, to some extent, on the role of Aβ. 
The oxidative stress hypothesis for the pathogenesis and progression of AD 
(Markesbery 1997, Butterfield, Drake et al. 2001, Butterfield, Reed et al. 2007) is 
based on the observations of increased cellular free radical production in AD. 
Such production is proposed to exceed the capacity to scavenge or otherwise 
neutralize these damaging moieties, leading to neuronal dysfunction and death 





Figure 2.1.2: PICTORIAL DEPICTION OF AMYLOIDOGENIC AND NON-
AMYLOIDOGENIC PROCESSING 
The  Aβ-induced  oxidative  stress  hypothesis  in  AD (Markesbery 1997, 
Butterfield, Drake et al. 2001)  is  supported  by Aβ-induced elevation of oxidative 
stress markers in brain, and subsequent neuronal degeneration (Frautschy, Baird 
et al. 1991). Senile plaques are composed of a core of Aβ surrounded by 
degenerating neurites. Aβ is derived by the proteolytic cleavage of amyloid 
precursor protein (APP) by action of β- and γ-secretases. Both Aβ(1-40) and 
Aβ(1-42) peptides, among other Aβ peptides, are found in human brain and 
the former two are the most abundant forms of this peptide. Aβ exists in at least 
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four aggregated states: monomers, oligomers, protofibrils, and fibrils. Recent 
data suggest that oligomeric Aβ is the toxic species of this peptide rather than 
Aβ fibrils themselves (Glabe 2005). Previous studies (Butterfield and Boyd-
Kimball 2005, Butterfield, Reed et al. 2007, Sultana and Butterfield 2010) have 
identified the single methionine residue at position 35 of Aβ(1-42) as a critical 
mediator of increased oxidative stress and neurotoxic properties of this peptide. 
Recent in vivo from our laboratory showed for the first the time methionine is 
critical to induce oxidative stress and consequently, a key player in amyloid β-
induced oxidative stress and AD pathogenesis (Sultana and Butterfield 2010, 
Sultana, Robinson et al. 2012). 
2.1.2.1 AMYLOID BETA PEPTIDE 
It has long been established that the role of oxidative stress in AD is a critical to 
the damage of vital cellular components such as proteins, lipids, and nucleic 
acids (Halliwell and Gutteridge 1984, Markesbery and Lovell 2006, Butterfield, 
Bader Lange et al. 2010, Weidner, Bradley et al. 2011). This damage if left 
unchecked is a primary reason for the eventual degeneration of neurons, 
possibly through both apoptotic means and necrotic means (Butterfield, 
Castegna et al. 2002). The Aβ-induced oxidative stress hypothesis proposed by 
our laboratory and others (Markesbery 1997, Butterfield, Drake et al. 2001), 
states that Aβ and the damage it initiates are the principal means underlying this 
injurious increase in oxidative stress observed in AD brain. 
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As discussed above, APP may be processed into two major isoforms of Aβ by 
way of β- and γ-secreteases; Aβ(1-40) and Aβ(1-42). Studies have demonstrated 
that as AD progresses, the levels of Aβ(1-40) in CSF remains relatively constant, 
while in contrast, levels of Aβ(1-42) in CSF decrease but levels of Aβ(1-42) 
increase in senile plaques (Tamaoka 1998). This distribution has been attributed 
to the possibility of an efflux deficiency for Aβ(1-42) which may play a role in 
plaque formation (Gustafson, Skoog et al. 2007, Owen, Sultana et al. 2010). 
Previously, plaques were perceived to be the primary pathogenic element of AD, 
yet more recently evidence provided insights into the notion that plaques may be 
an extra-cellular storage site for cells to deposit excess Aβ, suggesting the real 
damaging agent, may be a much smaller aggregate form of Aβ(1-42) oligomers 
(Walsh and Selkoe 2004, Glabe 2005). Research has shown that while plaques 
do not correlate with cognitive dysfunction in AD, soluble oligomers do (Tomic, 
Pensalfini et al. 2009). More recently, researchers have discovered in AD that 
distinct assemblies of Aβ oligomers impair cholinergic neurotransmission and 
long-term potentiation associated with learning and memory (Li, Jin et al. 2011, 
Bao, Wicklund et al. 2012). 
The Aβ-induced oxidative stress hypothesis places the majority of the causative 
effect of increased cellular oxidative stress upon oligomeric Aβ(1-42), as it is 
believed that only these hydrophobic oligomers are viable to insert into the lipid 
bilayer wherein they may form alpha-helices to begin the proposed catalytic ROS 
production that may lead to the lipid peroxidation and protein oxidation found in 
AD (Butterfield, Swomley et al. 2013). 
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While studies have found that oligomeric Aβ(1-42) correlates with increased 
oxidative stress, the exact method by which this occurs is still under debate 
(Tomic, Pensalfini et al. 2009). Strong evidence has been put forth by our lab and 
others that implicates the methionine-35 (Met-35) residue of Aβ(1-42) in the 
process of ROS generation. Since Aβ(1-42) is cleaved from APP, a 
transmembrane protein, our laboratory proposed that Aβ(1-42) oligomers are 
capable of re-entering the lipid bilayer where they may adopt an alpha-helical 
structure. In doing so, Met-35 would interact with the carbonyl of Ile-31 according 
to the i+4 rule of alpha-helices (Kanski, Aksenova et al. 2002). It is hypothesized 
that because the oxygen of the Ile-31 carbonyl group is more electronegative 
than the sulfur of Met-35, the electron density of the lone pairs of electrons are 
drawn away from the sulfur nucleus of Met-35 and are primed for oxidation by an 
extrinsic factor.  
Once the Aβ oligomers insert into the bilayer, the hydrophobic environment lends 
itself towards the stabilization of a one-electron oxidation of an already primed 
Met to the sulfuranyl free radical [MetS+] (Varadarajan, Kanski et al. 2001, 
Butterfield and Kanski 2002). It is this sulfuranyl free radical that is hypothesized 
as being the initiator in a series of free radical chain reactions that take place 
within the lipid bilayer that generate lipid peroxidation products and oxidatively 
modified membrane proteins (Butterfield and Kanski 2002, Butterfield and 
Sultana 2011). Substitution of amino acids in critical positions within the Aβ(1-42) 
peptide negate the injurious effects of Aβ(1-42).  For example, the substitution of 
Gly with Asp at residue 37 of Aβ(1-42) imparts a negative charge to the Aβ(1-42) 
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peptide that excludes the peptide from the lipid bilayer (Kanski, Aksenova et al. 
2002). Another substitution that replaces Ile-31 with the known α-helix breaker, 
proline, again alleviates oxidative stress induced by peptide, consistent with our 
hypothesis that the α-helical structure of Aβ(1-42) in the lipid bilayer is important 
for the production of oxidative stress (Kanski, Aksenova et al. 2002). 
Transgenic Caenorhabditis elegans that express human Aβ(1-42) demonstrated 
increased oxidative stress that was nullified by the substitution of Met-35 with 
another sulfur containing amino acid, Cys, in an attempt to demonstrate the 
differences in chemistry of the two sulfur atoms and their associated residencies 
(thioether vs. thiol) (Yatin, Varadarajan et al. 1999). In an in vitro study, Met-35 in 
Aβ(1-42) was substituted by norleucine, i.e., a methylene moiety for the S-atom 
of Met, to produce [Aβ(1-42)M35NLE]. This substitution produced a mutant 
peptide with an amino acid of similar length and hydrophobicity as the original 
Met-35. Aβ(1-42)M35NLE was unable to induce toxicity through oxidative stress 
by way of free radical generation (Yatin, Varadarajan et al. 1999, Clementi, 
Pezzotti et al. 2006, Dai, Sun et al. 2007, Murray, Bernstein et al. 2009). 
The J20 mouse, which is a transgenic mouse with human APP containing 
Swedish (KM670/671NL) and Indiana (V717F) mutations, showed elevated Aβ(1-
40/42) deposition and increased oxidative stress in brain (Robinson, Lange et al. 
2011). Introduction of a third mutation to APP, Met631Leu, corresponding to the 
Met-35 residue of Aβ(1-42), resulted in no oxidative stress in brain of these mice 
at 9 months of age (Sultana and Butterfield 2010). This result demonstrated in 
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vivo in a mammalian model what had been seen earlier in a worm model: Met-35 
of Aβ(1-42) is essential for oxidative stress in vivo in AD models, and presumably 
in AD brain as well. 
Important to note are other findings that provide evidence contrary to the Met-35 
centric hypothesis such as research conducted that used Aβ(25-35) instead of 
Aβ(1-42) with a substitution of Met-35 with norleucine at the c-terminal position 
that did not abrogate the oxidative induced by the peptide (Pike, Walencewicz-
Wasserman et al. 1995). These data, however, should be read with the 
understanding that a C-terminal Met displays altered chemistry from a Met within 
the α-helix (Varadarajan, Kanski et al. 2001). 
2.1.2.2 OXIDATIVE STRESS 
The oxidation of proteins by reactive oxygen species (ROS) within a cell has long 
been linked with not only the normal aging process (Harman 1956, Agarwal and 
Sohal 1996, Hohn, Konig et al. 2013), but also with a multitude of diseases that 
range from cancer (Ma, Zhang et al. 2013, Yang, Chay et al. 2013) to 
neurodegenerative diseases such as AD (Aksenov, Aksenova et al. 2001, Reed, 
Pierce et al. 2009, Di Domenico, Coccia et al. 2011). As with other post-
translational modifications (PTMs) of proteins, the oxidation of a peptide chain, 
indexed mostly by elevated protein carbonyls or 3-nitrotyrosine,  may alter the 
three-dimensional conformation of the peptide resulting in a gain or loss of 
function. While ROS has been shown to play a much larger cellular role in both 
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signaling and anti-microbial defense when tightly regulated by functioning ROS-
scavenging mechanisms, a loss of such scavenging mechanisms or an 
unhealthy increase in the cellular oxidants result in damage that takes the form of 
protein, lipid, and nucleic acid oxidation (Markesbery and Lovell 1998, Aksenov, 
Aksenova et al. 2001, Butterfield, Reed et al. 2006, Markesbery and Lovell 2006, 
Perluigi, Di Domenico et al. 2010, Weidner, Bradley et al. 2011). 
Protein oxidation refers to the direct or indirect damage afflicted to a protein 
during the process of an oxidative insult. There are four major forms of protein 
oxidation that are detectable by standard methods; these being protein 
carbonylation, protein nitration, protein bound-lipid peroxidation products, and 




Figure 2.1.2.2: OXIDATIVE STRESS DIAGRAM 
(Permission granted by Elsevier) 
When ROS such as O2-., H2O2, or .OH act directly upon a protein, protein 
carbonylation is a result, often forming reactive aldehydes or ketones by way of 
primary or a secondary mechanisms (Suzuki, Carini et al. 2010, Cabiscol, 
Tamarit et al. 2014). Primary protein carbonylation may occur via alpha-carbon 
hydrogen extraction, oxidation of the peptide backbone resulting in 
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fragmentation, and oxidation of amino acid side chains. Protein carbonylation 
normally refers to the reactive ketones or aldehydes that are formed as a product 
of direct free radical induced damage of proteins and can affect both the protein 
backbone as well as the side chains (Stadtman and Levine 2000). Direct protein 
carbonylation may result in the loss of function of the affected protein (Smith, 
Carney et al. 1992, Levine 2002). Primary protein carbonylation would be difficult 
to detect if not for the use of 2,4-dinitrophenylhydrazine (DNPH) that forms 
hydrazones that are detectable through immunochemical blotting (Levine, 
Williams et al. 1994, Suzuki, Carini et al. 2010). While many forms of protein 
oxidation are irreversible barring clearance from the cell, protein carbonylation 
may be remedied by carbonyl reductase. Protein carbonyls may be more than 
just cell stressors as new information points to protein carbonyls as a potential 
form of redox signaling through a reversible enzyme mediated system (Wong, 
Marcocci et al. 2010, Wong, Bansal et al. 2012). 
What is sometimes called “secondary protein carbonylation” is an indirect method 
of protein oxidation in that an intermediate molecule carries the initial free-radical 
product to the protein which then initiates the protein carbonylation adduct 
(Grimsrud, Xie et al. 2008, Suzuki, Carini et al. 2010). The brain is especially 
susceptible to the effects of lipid peroxidation due to the high concentrations of 
iron, high oxygen utilization, and high polyunsaturated fatty acids (PUFA) density 
(Reed, Pierce et al. 2009). One method for the initiation of lipid peroxidation 
occurs when a carbon centered radical is produced on a polyunsaturated fatty 
acid (PUFA) by the abstraction of an allylic hydrogen by some form of radical 
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present within the bilayer, for example the Met-35 resultant sulfuranyl radical of 
Aß1-42. Paramagnetic O2, which lacks a dipole moment, diffuses into the lipid 
bilayer where it may react with the carbon centered radical to form a lipid peroxyl-
radical (Butterfield, Castegna et al. 2002, Shichiri 2014). The lipid peroxyl-radical 
may then abstract an allylic hydrogen from an adjacent poly-unsaturated lipid 
which propagates the chain reaction and forms a lipid peroxide which may then 
undergo cleavage forming an array of possible reactive aldehydes such as F2-
isoprostane, 4-hydroxy-nonenal (HNE), and 2-propen-1-al (acrolein). HNE, for 
example, is primarily produced from arachidonic acid, an omega-6 PUFA with 
inflammatory and signaling properties of its own and is found in high 
concentrations within the lipid bilayer of the brain (Butterfield, Bader Lange et al. 
2010). This binding of an amphiphilic lipid moiety to a protein may induce a 
denaturing conformational change that is responsible for loss of function detected 
in samples with high levels of protein bound lipid peroxidation products (Sayre, 
Zelasko et al. 1997, Subramaniam, Roediger et al. 1997, Lovell, Xie et al. 2001, 
Sultana and Butterfield 2004) Other PUFAs that are of importance in the 
generation of lipid peroxidation products are linoleic acid (LA), docosohexenoic 
acid (DHA), among others (Shichiri 2014). While reactive aldehydes are a main 
by-product of lipid peroxidation, other deleterious effects such as loss of lipid 
asymmetry and apoptosis may follow (Bader Lange, St Clair et al. 2010). 
Reactive aldehydes have been found to deplete the cell of nucleophilic 
compounds that serve as antioxidants (GSH, lipoic acid, thioredoxin) by 
covalently modifying proteins via Michael addition in a secondary protein 
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carbonylation reaction (Yang, Wu et al. 2004). Protein-bound and free reactive 
aldehydes are being investigated as potential markers of oxidative stress and 
disease progression in conditions ranging from neurodegeneration to brain 
infarction (Igarashi and Kashiwagi 2011, Lee, Wong et al. 2012). While one result 
of lipid peroxidation is protein modification, the products of lipid peroxidation 
themselves are potentially dangerous due to their electrophilic nature as well as 
their tendency to act as oxidants (Morrow and Roberts, 2002). 
Protein nitration occurs following formation of peroxynitrite (ONOO-) from 
superoxide (O2.-) and nitric oxide (NO.) interacting. The latter molecule, nitric 
oxide (NO.), is a molecular radical and important second messenger produced 
from L-argenine using one of three nitric oxide synthase (NOS) variants, is vitally 
important in some biological pathways such as vasodilation, inflammation, and 
immune response (Nelson, Connolly et al. 2003, Calabrese, Cornelius et al. 
2009, Shahani and Sawa 2011). High concentrations of NO., through secondary 
reactions with ROS, may go on to produce other reactive nitrogen species 
(RNS), such as NO2, N2O3, and ONOO-. These compounds react with the metal 
cofactors of enzymes, the peptide backbone, and specific amino acids such as 
tyrosine, cysteine, and tryptophan which are generally more readily modified by 
nitrosative stress (Stamler 1994). Peroxynitrite, in the presence of CO2, is known 
to covalently modify tyrosine residues to produce 3-nitrotyrosine (Butterfield and 
Kanski 2001, Butterfield, Reed et al. 2007). The formation of 3-nitrotyrosine has 
been found to inactivate key proteins such as actin, manganese superoxide 
dismutase (MnSOD), copper/zinc superoxide dismutase (Cu/Zn SOD), and 
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tyrosine hydroxylase. Due to the steric constraints placed on the OH functionality 
of tyrosine residues by the addition of a large nitro group in the 3’ position, 
difficulty in phosphorylating the tyrosine, via tyrosine kinases, may occur 
(Butterfield DA 1997a). Research on aging rats has shown that nitrated tyrosine 
residues may play an important role in the aging process, as protein nitration 
levels increase with age in the cerebellum, substantia nigra, hippocampus, 
semimembranosus and soleus muscle, as well as localized to membrane raft 
proteins that may play a significant role in cell signaling processes (Dremina, 
Sharov et al. 2005, Fugere, Ferrington et al. 2006, Poon, Calabrese et al. 2006, 
Gokulrangan, Zaidi et al. 2007).  
Methionine has been found to be exceptionally prone to oxidation in vivo when 
exposed to high levels of oxidative stress, resulting in the sulfoxidation products 
Met-sulfoxide [Met(O)] and Met-sulfone [Met(O2)] (Moskovitz, Maiti et al. 2011). 
While the Met-sulfone is generally an irreversible product of sulfoxidation, Met-
sulfoxide, may yet be converted back to Met via the methionine-sulfoxide 
reductase (Msr) pathway (Oien and Moskovitz 2008). Sulfoxidation has been 
implicated in aging disorders such as AD, in which a large percentage of Aβ in 
amyloid plaques has been found to contain the sulfoxide modification on Met35 
(Kuo, Kokjohn et al. 2001, Boutte, Woltjer et al. 2006). In fact, the highly reactive 
nature of Met35 in Aβ is of such importance, that, as noted above, it is the central 
theme within the Aβ induced oxidative stress hypothesis, put forth by our 
research group (Varadarajan, Yatin et al. 1999, Sultana and Butterfield 2010, 




Proline is an amino acid that may adopt one of two spatial conformations within a 
peptide. These two conformations are referred to as cis and trans 
orientations, of which the isomerization between the two is known to be a slow 
step in protein folding. Pin1, or Protein Interacting with NIMA (never in mitosis-A), 
is a PPIase (peptidyl-prolyl cis/trans isomerase) of the parvulin subfamily that 
specifically acts upon protein substrates with the motif of phosphorylated Ser/Thr 
on the amino- terminal side of an adjacent Pro (pSer/Thr-Pro) (Lu, Hanes et al. 
1996). 
Our group demonstrated that not only was Pin1 oxidatively modified in age 
matched control AD hippocampus, but that the activity as well as the protein 
expression of Pin1 were both found to be significantly reduced (Sultana, Boyd-
Kimball et al. 2006). The implications of this finding are vast when considering 
the large amount of literature that links Pin1 as a crucial regulator of intracellular 
processes. When considering AD, Pin1 has been shown to regulate both directly 
and indirectly amyloid precursor protein (APP) and Tau, the proteins of which 
constitute the primary components of the neuropathological hallmarks β-amyloid 
plaques and NFTs, respectively. In normal brains, Pin1 has been shown to 
induce dephosphorylation of Tau at key sites via regulation of protein 
phosphatase 2-A (PP2A), and consequently the knock down of Pin1 leads to 










Interestingly, Pin1 has been shown to act on the intracellular C-terminal domain 
(AICD) pT668-P of APP to direct processing of this protein toward the non- 
amyloidogenic pathway (Pastorino, Sun et al. 2006). More recently, it has been 
found that Pin1 interacts with and inhibits the kinase activity of glycogen 
synthase kinase 3-β (GSK3β) that has been implicated in both Tau 
hyperphosphorylation as well as directing APP toward the amyloidogenic 
pathway (Ma, Pastorino et al. 2012). The discovery that Pin1 both directly 
associates with the protein precursors to the classical AD pathological hallmarks 
as well as the protein kinase systems that contribute to this pathology, illustrates 
not only the complex and integral control that Pin1 exerts over this system, but 
also the potential ramifications that an oxidized and dysfunctional Pin1 could 
have. 
2.2.1 PIN1 IN AD/MCI 
In normal non-neuronal cells, the means in which cells divide is through the 
induction of the cell cycle creating two daughter cells from one parental cell. This 
process may be classified  into four distinct segments (G1, S, G2, M); two growth 
phases G1 and G2, which themselves are built around an S phase during which 
DNA is replicated, followed by the M phase, or mitosis, which consists of 
chromosomal as well as cellular separation into two distinct daughter cells. In an 
effort to control abnormal proliferation of cells through the different phases of the 
cell cycle, regulatory points exist that the cell must fulfill for division to 
proceed. These checkpoints exist between the phases and are maintained by 
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numerous control proteins. Neurons in a typical non-disease brain of an adult 
remain in what is called a quiescent state (the Go phase) wherein the cell cycle 
has been halted. Neurodegenerative diseases in which the protein Tau is key 
demonstrate aberrant cell cycle reentry of quiescent neurons and has been 
shown to proceed through multiple cell cycle check points, yet ultimately failing to 
complete mitosis, and proceeding to apoptosis. 
To date, a large number of control proteins important to the cell cycle have been 
identified as having aberrant expression, localization, or posttranslational 
modifications in AD (Bonda, Lee et al. 2010, Keeney, Swomley et al. 2012). 
Moreover, cell cycle proteins have been found to have irregular expression in 
earlier stages of AD. Our group reported that levels of CDK2, CDK5, and cyclin 
G1 were elevated in both the hippocampus and IPL in brains of subjects with 
aMCI, demonstrating that cell cycle changes may appear prior to the classical AD 
diagnosis (Sultana and Butterfield 2007, Keeney, Swomley et al. 2012). 
While induction of neurons into the cell cycle by ambiguous means has been shown 
to be characteristic of AD, the progression and ultimate failure of the neuron to 
complete the cell cycle remains to be clarified in its own right, possibly due to the vast 
complexity of cell cycle control. Interestingly, not only does Pin1 interact with and 
promote cell cycle entry, but Pin1 has also been found to be associated with a 
number of proteins fundamental to the progression and completion of the cell cycle; 




Pin1 has been found to regulate the tumor suppressor p53, a protein of significance 
in controlling cell proliferation, through multiple mechanisms including increasing 
p53 stability through the interaction of p53 with the E3 ubiquitin ligase murine 
double minute-2 (Mdm-2), facilitating the DNA binding of p53 to a number of pro-
apoptotic promoter sites under conditions of cellular stress, enhancing p53 
acetylation by p300 or CREB response binding protein (CBP) acetylases, and the 
dissociation of p53 from the inhibitor of apoptosis-stimulating protein of p53 
(iASPP), which is a key inhibitor of p53 (Mantovani, Tocco et al. 2007). In addition 
to p53, Pin1 has been implicated as a crucial player in the regulation of 
phosphorylated retinoblastoma protein (pRb), a key mediator of the G1/S phase 
transition. Evidence demonstrates that Pin1 plays a crucial role in the association 
of pRb with CDK/Cyclin complexes and release of E2F transcription factors 
important for entry into the S-phase (Rizzolio, Lucchetti et al. 2012). Pin1 has 
been shown to directly affect the stability of the cell cycle inhibitor p27kip1 via 
interaction with the SCFskp2 (skp, cullin, F-box containing complex) E3 ubiquitin 
ligase complex (Zhou, Yang et al. 2009). 
The finding of an oxidized and dysfunctional Pin1 makes a significant contribution 
to the two-hit hypothesis of AD proposed by Zhu et al., providing a direct link in 
which increased oxidative stress in conjunction with cell cycle abnormalities play 





2.3 RESVERATROL AND RHESUS MONKEY PARIETAL LOBE 
 
The Western diet has been under much scrutiny in the past two decades due to 
the abundance of saturated fat and refined sugar (HFS) content commonly used 
in food preparation. Long term HFS consumption has been linked to a number of 
physiological conditions such as obesity, insulin resistance and type-2 diabetes 
mellitus, cardiac disease, ischemia, cancer, and cognitive dysfunction (Myles 
2014). The projected costs of obesity-related diseases is not only measured in 
monetary terms but also in life-years used to treat the disease and life-years lost 
to early death associated with obesity. While much research has been completed 
in uncovering the effects of chronic obesity on the endocrine and circulatory 
systems, there is still much to learn about the effects of obesity and the role it 
plays in cognitive decline. It has been long thought that cognitive dysfunction is 
directly tied to chronic metabolic low grade inflammation and vasculitis that 
accompanies obesity.  
 
Resveratrol (RSV) is a polyphenol found primarily in skins of red grapes, 
blueberries, cranberries, nuts such as peanuts and pistachios, as well as in 
cocoa. RSV has garnered widespread acclaim due to the many studies that link 
RSV to beneficial effects, such as neuroprotection, anti-inflammation, regulation 
of metabolic pathways and improvement of glucose tolerance, and its use as an 
antioxidant (Carrizzo, Forte et al. 2013, Bastianetto, Menard et al. 2014, 
Szkudelski and Szkudelska 2014, Poulsen, Fjeldborg et al. 2015). The mode of 
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action for RSV appears to be its indirect activation of the NAD+-dependent 
deacetylase, sirtuin-1 (SIRT1), possibly through the inhibition of cyclic AMP 
(cAMP)-degrading phosphodiesterase, that leads to the deacetylation of the p65 
subunit of NF-κB (Howitz, Bitterman et al. 2003, Blander and Guarente 2004, 
Dai, Kustigian et al. 2010, Park, Ahmad et al. 2012). 
 
While much research has been conducted on RSV in a number of scenarios and 
models, a proteomic analysis of the primate brain when subjected to differing 
diets has yet to be shown. This dissertation study aimed to fill that gap by 
comparing and contrasting the proteome of Rhesus monkey parietal lobe, raised 
on three different diets: a control diet, a HFS diet, and a HFS+RSV diet. The 
parietal lobe of the brain is primarily responsible for the integration of sensory 
information, both tactile and perceived, as well as spatial recognition and the 
processing of language. Impairments to the parietal lobe are seen in a number of 
neurodegerative diseases such as AD, Parkinson disease, and amyotrophic 
lateral sclerosis (Cosottini, Pesaresi et al. 2012, Teixeira, Machado et al. 2014, 
Brickman, Zahodne et al. 2015).  By gaining insights into the proteome changes 
associated with the diets and the influence of RSV, better understanding of the 






CHAPTER 3: EXPRESSION PROTEOMICS OF PIN1 OVEREXPRESSION IN 


















3.1 STUDY OVERVIEW 
The peptidyl-prolyl-(cis/trans)-isomerase (PPIase) PIN1 has been associated 
with the major pathological hallmarks of Alzheimer disease (AD) progression 
such as amyloid precursor protein processing, tau-phosphorylation state, and cell 
cycle control. Here, we used an adeno-associated-virus (AAV) to upregulate 
PIN1 production in an APP/PS1 AD mouse model while using a GFP control. 
Using expression proteomics, a number of proteins were identified as presenting 
with differential levels resulting from PIN1 upregulation, important to multiple 
cellular subsystems such as energy production, structural integrity, and signaling.  
 
3.2 INTRODUCTION 
Alzheimer disease (AD) is a degenerative neurological condition that impairs 
memory and cognitive function primarily in seniors, yet has been found to be 
distinguishable from the normal aging process. Though the primary cause of AD 
is heavily debated, there are fundamental consistencies in pathological hallmarks 
that exist in AD such as Amyloid-beta-42 (Aβ-42) plaques and oligomers as well 
as neurofibrillary tangles (NFTs) of the cytoskeletal protein Tau (Pastorino, Sun 
et al. 2006, Balastik, Lim et al. 2007). While Aβ-42 and Tau have received the 
majority of the attention of AD researchers, the role of the cell cycle and its 
regulatory processes have begun to appear to be key players as well in the 
progression of AD (Bonda, Lee et al. 2010, Keeney, Swomley et al. 2012, Lin, Li 
et al. 2015). Though these pathological hallmarks and processes may appear 
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disparate, the peptidylprolyl-(cis/trans)-isomerase (PPIase) PIN1 (protein-
interacting-with-NIMA (Never-in-mitosis-A)-1) has been found to be intricately 
involved in what appear to be all major areas affected by AD and thus warrants 
further investigation (Wulf, Liou et al. 2002, Butterfield, Abdul et al. 2006, 
Pastorino, Sun et al. 2006). 
PIN1 primarily functions as a regulator of proteins, utilizing its PPIase function to 
activate target proteins through the mechanical means of proline cis/trans 
isomerization (Zhou, Lu et al. 1999). PIN1, unlike many other PPIases, is 
phosphorylation specific and primarily recognizes the target protein amino acid 
motif of pSer/pThr-Pro. While the isomerization of this bond may produce drastic 
structural rearrangements, it also has the effect of modifying the availability of 
targeted phosphorylation site to the cytosol, and subsequently, to phosphatases. 
Because of this, PIN1 has been likened to an intracellular protein clock, or timer, 
by altering the time-frame a protein may be activated/inactivated through 
phosphorylation (Lu, Finn et al. 2007). PIN1 often times acts upon multiple levels 
of a signaling network, as evidenced in its role in amyloid precursor protein (APP) 
processing as PIN1 both works directly upon APP as well protein kinases and 
phosphatases such as CDK-5 and PP2A that phosphorylate and 
dephosphorylate APP, respectively (Butterfield, Abdul et al. 2006). 
The intricate control that PIN1 has over the many processes that go awry in AD 
is only compounded by the fact that PIN1 is both oxidatively damaged and its 
levels are significantly decreased in AD brain, as was evidenced by work from 
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our laboratory and those of our collaborators (Sultana, Boyd-Kimball et al. 2006, 
Chen, Li et al. 2015).  
Here, we used an adeno-associated-virus to upregulate levels of PIN1 in an AD 
mouse model in an attempt to replenish or even protect against the eventual loss 
of basal PIN1 levels that accompanies AD progression. Utilizing expression 
proteomics, we have identified a number of proteins found to have differential 
levels when compared to GFP controls that these identified proteins may play 
important protective roles, due to the expansive control that PIN1 exerts over the 
cell. We expect these findings to be important contributions to the understanding 
of what we believe to be a critical regulatory protein impaired during AD. 
 
3.3 MATERIALS AND METHODS 
3.3.1 ANIMALS 
The mouse models used in this experiment were genotyped and obtained from 
the Michael P. Murphy laboratory at the University of Kentucky, Lexington KY. 
For use in the experiments performed, four distinct mouse models were used:  
APPΔNL/ΔNL/PS1P264L/P264L (APP/PS1) were used for both groups (control; GFP: 
and experimental; Pin1). The mice were housed in an AALAC-approved animal 
facility with a 12-hour light-dark cycle and fed the standard rodent chow ad 
libitum. Prior to any experiment involving the use of animal models, University of 
Kentucky (UK) IACUC approval was obtained and all work herein was performed 
in accordance with all federal specifications. 
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All animals were subjected to IACUC approved wellness checks regularly and 
throughout the duration of the study timeframe. Any animal deemed unfit to 
continue the study due to perceived suffering was immediately euthanized.  
3.3.2 VIRAL UPREGULATION OF PIN1 AND GFP 
APP/PS1 mice were bred from a set of two breeders. Upon birth, the mouse 
pups were anesthetized on ice inside an insulating pouch until immobile, where 
they were individually taken and injected in the temporal lobe with 2 µL of either 
AAV with PIN1 or GFP. The mice were closely watched for complications and 
separated by gender at 3 weeks. 
3.3.3 SAMPLE PREPARATION 
The brains from the mice were thawed and individual homogenates were 
prepared using a wheaton glass homogenizer (approximately 40-45 passes) with 
ice-cold isolation buffer [0.32M sucrose, 2mM EDTA, 2mM EGTA, 20mM HEPES 
buffer, 0.2µg/ml PMSF, 4µg/ml leupeptin, 4 µg/ml pepstatin, 5µg/ml aprotinin]. 
Homogenates were subsequently vortexed followed by sonication on ice for 10s 
at 20% power, two times, allowing the sample to rest 20s on ice between 
vortexings, with a Fisher 550 Sonic Dismembrator (Pittsburgh, PA, USA). 
Concentration of the protein in the homogenates was determined by the Pierce 





3.3.4 PIN1 OVEREXPRESSION VALIDATION 
In order to validate the efficacy of the injections, a western blot of Pin1 levels as 
compared to GFP controls (1 month, 6 month, 9 month, and 12 month) was 
conducted using western-blot analysis and an anti-Pin1 antibody (Santa Cruz, 
CA, USA). The Pin1 levels were standardized to internal standard tubulin levels 
using an anti-tubulin antibody raised in goat (Santa Cruz, Ca, USA). 
 
3.3.5 TWO-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS 
(2D-PAGE) 
3.3.5.1 ISOELECTRIC FOCUSING 
Brian tissue homogenates (200 µg) were shaken in 200 µl of rehydration buffer 
[8M urea, 2.0% (w/v) CHAPS, 2 M thiourea, 50 mM dithiothreitol (DTT), 0.2% 
biolytes, 0.01% bromophenol blue] for 1.5 hr at RT followed by sonication for 10 
s at 20% power. The sonicated samples were applied to 11 cm pH 3-10 
ReadyStripTM IPG strips with a linear gradient. IPG strips were actively 
rehydrated at 20°C for 18 h at 50 V using a Bio-Rad Protean IEF Cell (Hercules, 
CA, USA). After 60 min, 2 mL of mineral oil was added to the strips to prevent 
dehydration. After 18 hours, isoelectric focusing was performed at a constant 
temperature of 20 °C starting at 300 V for 2 h, 500 V for 2 h, 1000 V for 2 h, 8000 
V for 8 h, and finishing at 8000 V for 10H. The IPG strips were then removed 
upon cycle completion and stored at -80°C immediately following removal and 
stored until future use. 
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3.3.5.2 SDS PAGE 
IPG strips of Pin1 and GFP samples were first thawed for 10 min followed by 4 
ml of a DTT-containing equilibration buffer [50 mM Tris-HCl, pH 6.8, 6 M urea, 
1% (w/v) SDS, 30% v/v glycerol, 0.5% DTT] for 10 minutes in the dark. The strips 
were then removed from the solution and placed in clean plastic wells where 4 
mL of an iodoacetamide-containing buffer [50 mM Tris-HCl, pH 6.8, 6 M Urea, 
1% (w/v) SDS, 30% v/v glycerol, 4.5% iodoacetamide] was added in the dark. 
The IPG strips were rinsed in a 1x dilution of TGS running buffer and placed into 
Criterion precast linear gradient (8-16%) Tris-HCl polyacrylamide unstained gels. 
Precision Plus ProteinTM All Blue molecular weight marker was added and 
agarose gel was overlaid. Pin1 and GFP Gels were run at a constant voltage of 
200 V for approximately 60 min using 1x Tris/Glycine/SDS running buffer. 
3.3.5.3 IMAGE ANALYSIS 
Spot intensities of the Pin1 and GFP imaged unstained gels were quantified by 
densitometry using PDQuest 2-D Analysis Software (Bio-Rad, Hercules, CA, 
USA). Individual gel spot intensities were normalized to the total density of the 
individual gel. Spot densities from the two experimental groups at each time point 
(GFP: 1 month, 6 month, 9 month, 12 month; Pin1: 1 month, 6 month, 9 month, 
12 month) were compared and the spots with a statistically significant difference 
based on two-way ANOVA and Bonferonni multiple comparisons were 




3.3.5.4 SYPRO RUBY STAINING 
Following 2D-PAGE, and PDQuest  analysis, sample gels (Criterion precast 
linear gradient (9-16%) Tris-HCl polyacrylamide gels) were run rollowing the 
same procedure but fixed in solution [7% (v/v) acetic acid, 10% (v/v) methanol] 
(50 mL) for 45 min at RT on a gently orbiting platform. After fixing, the solution 
was removed and 50 mL of Sypro Ruby® Protein Gel Stain was added to stain 
proteins in the gel overnight (15 h) at RT with gentle orbiting. Gels were rinsed 
and transferred to 50 mL of deionized water at RT until scanning. The Gels were 
scanned utilizing a Bio-Rad ChemiDocTM XRS+ imaging system (Hercules, CA) 
and subsequently stored in deionized water at 4°C until extraction of protein 
spots. 
3.3.5.5 IN-GEL TRYPSIN DIGESTION AND PEPTIDE EXTRACTION 
Pin1 and GFP protein spots were identified as significant utilizing PDQuest 
software and excised from 2D-gels followed by transfer to Eppendorf micro-
centrifuge tubes. 20 μL of 0.1 M ammonium bicarbonate (NH4HCO3) were added 
to the tubes and allowed to incubate at RT for 15 min. Then, 30 μL of acetonitrile 
were added to each tube and again, incubated at RT for 15 min. The solvent was 
then removed and the gel plugs were allowed to dry at RT for 30 min. 30 μL of 20 
mM DTT in 0.1 M ammonium bicarbonate was added to the gel plugs and 
incubated for 45 min at 56°C. After the removal of the DTT/NH4HCO3 solution, 30 
μL of 0.05 M iodoacetamide (IA) in 0.1 M NH4HCO3 were added and incubated at 
RT for 15 min. The IA solution was removed and 150 μL  of 0.05 M NH4HCO3 
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were added to incubate for 15 min at RT. 200 μL of acetonitrile (CAN) were then 
added to the solutions and incubated for another 15 min. Gel plugs were dried for 
30 min at RT before rehydrating with 10 μL of modified trypsin solution in 0.05 M 
NH4HCO3. Plugs were incubated at 37 °C and shaken at 230 RPMs overnight 
(15 hrs.). The digested solution was transferred into Eppendorf tubes while 20 μL 
of a 5% CAN, 0.1% formic acid (FA) solution was added to the old tube 
containing the gel plug and sonicated in a RT water-bath for 15 min. Following 
water-bath sonication, 30 μL of a 95% CAN, 0.1% FA and 0.001 M NH4HCO3 
solution were added and water-bath sonicated for 15 min. The solution was then 
removed from the gel plug tube and combined with the supernatant digest 
solution. Using a Speed-Vac, the digest solution samples were concentrated to a 
volume of 10 μL. C18 ZipTips were used to remove salts and contaminants from 
the trypsin-digested peptide solution using the following procedure. 10 μL of 
100% CAN were aspirated into the ZipTip and expelled 5 times, followed by 10 
μL of a 50% CAN solution containing 0.1% FA, which were aspirated and ejected 
5 times. The trypsin digested solution was drawn and pushed out of the miceo-
column a total of 10 times to allow for peptide adherence to the column. 
Contaminants were eliminated from the peptides in the ZipTip by washing with 10 
μL of a 5% CAN and 0.1% FA solution by aspirating and expelling the eluent 5 





3.3.5.6 NANOLC-MS WITH DATA DEPENDENT SCAN 
The Pin1 and GFP samples were analyzed by a nanoAcquity (Waters, Milford, 
MA)-LTQ Orbitrap XL (Thermo Scientific, San Jose, CA) system in a data-
dependent scan mode. A packed capillary column (0.1 x 130 mm column packed 
with 3.6 μm, 200 angstrom XB-C18) and a gradient with 0.1% FA and CAN/0.1% 
FA at 200 nL/min were used for separation. The MS spectra were acquired by an 
orbitrap at 30,000 resolution and MS/MS spectra of the six most intense ions in 
the MS scan were attained by the orbitrap at 7,500 resolution. The resultant data 
files from each sample were then searched against the most current version of 
the Swiss-Prot database by SEQUEST (Proteome Discoverer v1.4, Thermo 
Scientific). A minimum of two high-confidence peptide matches were required for 
protein identification (false discovery rate <1%). Proteins that are matched with 
the same peptides are reported as one protein group. Resultant MS/MS data 
were first verified by a comparison of the expected molecular weight and 
isoelectric point of the identified protein to that of the extracted plug from the 2-D 
gel. 
3.3.6 ONE-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS 
(1D-PAGE) 
Brain homogenates (50 μg) of Pin1 or GFP samples were suspended in 4x 
sample loading buffer [0.5 M Tris, pH 6.8, 40% glycerol, 8% SDS, 20% β-
mercaptoethanol, 0.01% Bromophenol Blue] and diluted to 1x with deionized 
water. Samples were heated at 95 °C for 5 min in a hot water-bath, then cooled 
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on ice, and loaded into a CriterionTM precast (4-12%) Bis-Tris polyacrylamide 18 
well gel with Precision Plus ProteinTM All Blue Standards. Gels were run at RT in 
a Criterion CellTM vertical electrophoresis buffer tank (Bio-Rad, Hercules, CA, 
USA) containing a 1x dilution of XT MOPS running buffer at 80 V for 15 min. The 
voltage was subsequently increased to 120 V for the duration of the 
electrophoretic run (~100 min). 
3.3.6.1 1D-WESTERN BLOTTING 
Proteins from the gel were transferred to a nitrocellulose membrane (0.2 nm) 
using a Trans-Blot TurboTM Blotting System (Bio-Rad, Hercules, CA, USA). 
Following transfer, membranes were placed in a blocking solution of 3% bovine 
serum albumin (BSA) in Wash Blot [150 mM NaCl, 3 mM NaH2PO4, 17 mM 
NaHPO4 and 0.04% (v/v) Tween 20] at RT for 1.5 h. Pin1 was detected with 
polyclonal primary antibodies raised in rabbits (1:8000 dilution in blocking 
solution). The blots were incubated at RT with rocking for 2 h. The membranes 
were then rinsed three times in Wash Blot (5 min, 5 min, 10 min), followed by a 1 
h incubation with rabbit horseradish peroxidase (1:3000) secondary antibody at 
RT with gentle rocking. Blots were rinsed three times (5, 10, and 10 min) in Wash 
blot and developed by chemiluminescence using ClarityTM Western ECL 
Substrate. After developing for 5 min at RT in the dark, blots were scanned using 
a Bio-Rad ChemiDocTM XRS+ imaging system and quantified using Image LabTM 
software (Bio-Rad, Hercules, CA, USA). The membranes were rinsed with Wash 
Blot for 5 min, two-times, and stripped with RE-Blot Plus Strong solution for 
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exactly 10 min at RT, followed by three 5 min rinses with Wash Blot. The 
resultant membranes were then blocked once again in 3% BSA for 1.5 h. Then, 
anti-tubulin antibodies raised in mice (1:20000) were added to the Wash Blot 
solution for 2 hours at RT. Membranes were washed and incubated with a 
secondary HRP-conjugated antibody, washed, developed colorometrically, and 
scanned as previously described. 
3.3.7 STATISTICAL ANALYSIS 
An ANOVA was performed and followed by a Bonferroni correction in order to 
correct for multiple comparisons in order to determine the effects of Pin1 over-
expression on the expression of pin1-target proteins within the tissue of the 
APP/PS1 mouse brain as a function of age. An α<0.05 was selected as a 
measure of significance for the ANOVA while a p<0.05 was selected as a 
measure of significance for the multiple comparisons test. Fold-change values of 
the differentially expressed proteins were then determined by dividing the 
average spot intensity of the gels from the GFP or Pin1 groups by the average 
spot intensity of the gels of the GFP group within an age group. Proteins that 
were identified by the SEQUEST search algorithm with p<0.01 were considered 
to be statistically significant. To validate MS/MS identification of the significant 
differentially expressed proteins, the position of protein spots on the 2D-gel 
images were first examined to confirm that they were located near the expected 






3.4.1 PIN1 EXPRESSION ANALYSIS 
In order to first determine if the injections of AAV containing PIN1 to brain was 
successful, western-blot analysis was performed using an anti-Pin1 antibody. At 
one month, PIN1 was found to be approximately 3.5-fold higher levels than the 
GFP control (p<0.01), the 6-month group showed just under 3.0-fold higher levels 
than the GFP control (p<0.0002), the 9-month group displayed again, nearly 3.5-
fold higher levels of PIN1 than the GFP group (p<0.1), and finally the 12-month 
group was found to be over 7-fold higher levels of PIN1 than the GFP control 
(P<0.0002). Using these findings, we feel confident that the injections of PIN1 
were successful in their over-expression of PIN1 protein in the APP/PS1 mouse 
brain, while the GFP control did not. 
 
In order to determine the overexpression of Pin1 samples, only the Pin1 samples 
showing overexpression were used for the analysis. Because the injection of 
AAV showed no signs of success or failure until post-mortem analysis, it is 
assumed that the virus injection was only successful in those samples showing 
















































































































3.4.2 PROTEOMICS ANALYSIS 
Proteomic analysis of the proteins of the Pin1 vs GFP groups were conducted 
using a 2D-PAGE approach with Sypro Ruby staining. Protein spot intensities 
were compared between these eight groups to determine differentially expressed 
proteins. Figure 3.4.2 shows representative examples of 2-D gel images of the 
isolated proteins from the brain of the Pin1 vs GFP mouse model by the average 
spot intensity of the GFP gel spots with respect to age. For example, a fold 
increase of 1.50 in the Pin1 12-month age group represents a 50% increase in 
protein expression of the 12-month age group with respect to the group used as 
a control. A fold value less than 1, denotes a decrease in protein expression, for 
example a fold of 0.5 represents a decreased protein expression of 50%.  
 
As shown in Tables 3.4.2, the proteins were identified by more than one peptide 
sequence. Furthermore, proteins that were identified by MS/MS analysis were 
first validated by visually comparing the known molecular weight and isoelectric 
point provided by Sequest software to the relative position of extracted protein 
spot on the gel. Table lists the 10 significant differentially expressed proteins 
identified in the comparison of the Pin1 and GFP mouse models were: 
Neurofilament light polypeptide:1609 (↑2.1-fold, p=0.02, 12MP v 12MG), 
Immunity-related GTPase Family Q protein:1616 (↑3.3-fold, p=0.03, 12MP v 
12MG), Phosphatidylethanolamine-binding protein-1:2106 (↑98.6-fold, p=0.02, 
1MP v 1MG), Myc box-dependent-interacting protein 1:3106 (↑1.7-fold, p=0.09* 
46 
 
(T-test, not significant but trending), 9MP v 9MG), Actin-related protein-3:3513 
(↑2.1-fold, p=0.03, 9MP v 9MG), D-dopachrome decarboxylase:4007 (↑1.9-fold, 
p=0.04, 9MP v 9MG), Growth factor receptor-bound protein 2:4201 (↑0.21-fold, 
p=0.0007, 9MP v 9MG), Glycerol-3-phosphate dehydrogenase:6302 (↑2.1-fold, 
p=0.01 9MP v 9MG), Carbonic Anhydrase:5312 (↑3.5-fold, p=0.002, 9MP v 
9MG), Cofilin 1:8109 (↓0.52-fold, p=0.35*(Ttest, not significant but worth 

























Figure 3.4.2a Neurofilament Light Chain level vs time 
 





























Figure 3.4.2c PEBP1 level vs time 
 




























Figure 3.4.2e ARP3 level vs time 
 



























Figure 3.4.2g GRBP2 level vs time 
 

























Figure 3.4.2i G3PD level vs time 
 





































3.5 DISCUSSION OF RESULTS 
As mentioned, Pin1, has been implicated as an important mediator of many of 
the major AD pathological hallmarks (Lu, Wulf et al. 1999, Butterfield, Abdul et al. 
2006). Pin1 is a peptidyl-prolyl cis/trans isomerase that specifically functions on 
pin1 protein targets with a phosphorylated-ser/thr n-terminal to a proline motif in 
order to enact a three-dimensional configurational rearrangement which imparts 
a function change for the target protein (Lu, Wulf et al. 1999). Moreover, Pin1 has 
been found interact with both amyloid precursor protein and protein tau directly, 
and indirectly through the modification of protein kinases and phosphatases (Lu, 
Wulf et al. 1999, Zhou, Kops et al. 2000, Ma, Pastorino et al. 2012). Our 
laboratory has shown in the past that Pin1 is both oxidatively modified as well as 
decreased in level in AD (Sultana, Boyd-Kimball et al. 2006). This decrease likely 
results in aberrant effector protein activity which would likely have far reaching 
consequences in protein activity and even expression given Pin1’s role as a cell 
cycle regulator (Wulf, Liou et al. 2002). More recently, we found that the active 
site of Pin1, Cys-113, is oxidatively modified which impedes its catalytic activity 
and therefore, function (Chen, Li et al. 2015). Our hypothesis throughout the 
current dissertation study was that through the upregulation of Pin1 protein levels 
by way of a vector, protein expression would be altered and proteins with 
protective effects with respect to AD progression would be upregulated. 
 
3.5.1 PIN1 PROTEIN LEVELS 
To determine the effects of AAV up-regulation of Pin1 in APP/PS1 AD mice, first 
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it must be shown that the viral upregulation of Pin1 protein took place. Figure 
3.4.1a shows that even at one month, Pin1 levels were increased at 
approximately 3.5-fold levels of that of the GFP controls. The trend continued 
with the 6-month age group as figure 3.4.1b depicts with a 3.0-fold increase in 
Pin1 protein levels. Figure 3.4.1c shows that at 9 months Pin1 protein levels 
were again, 3.5-fold higher than GFP controls and at 12 months, Figure 3.4.1d 
demonstrates that Pin1 levels were approximately 7-fold higher than that of the 
GFP controls. It should be noted here, that the 12-month age group was injected 
first so as to let those mice begin aging. Because they were the first group, the 
injections were not as effective as those of the other age groups, therefore in 
these calculations the mice that showed no noticeable increase in Pin1 over GFP 
were excluded and it was assumed that the injections failed as all other mice 
injected displayed drastic increases in Pin1 production. However, for the duration 
of the oxidative stress measurements, all samples were included despite their 
corresponding Pin1 levels in order to ensure a rigorous testing and that faith in 
the results would be assured. 
 
3.5.2 EXPRESSION PROTEOMICS 
Pin1 is a complex regulatory protein, playing roles in many subcellular systems 
such as immunity, cell cycle control, transcription, as well as apoptosis and 
cellular damage response (Yaffe, Schutkowski et al. 1997, Winkler, Swenson et 
al. 2000, Zhou, Kops et al. 2000, Ryo, Nakamura et al. 2001, Wulf, Ryo et al. 
2001, Butterfield, Abdul et al. 2006). Therefore, it is important to investigate the 
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downstream effects and protein levels that may be impacted by Pin1 
upregulation, as the artificially increased levels may have unanticipated 
widespread effects, be they beneficial or detrimental to the health of the cell. To 
this end, discovery based expression proteomics was employed to investigate if 
the upregulation of Pin1 protein levels impacted the levels of any other proteins 
significantly altered. 
 
After a rigorous two-way ANOVA, 8 proteins were found to have a significant 
differential expression (2 proteins either close to significance or presenting 
interesting trends were also included) with Pin1 upregulation when compared to 
GFP controls (Table 3.4.2). These proteins, described in detail below, are 
representative of many different subcellular systems including energy production, 
cellular signaling, transcription control, immune response, and cellular structure. 
 
 Neurofilament-light (NFL) is an intermediate filament vital to the overall structure, 
growth, and plasticity of the neuron. One of the first cytoskeletal aberrations 
presented in the neocortex in AD is the alteration of NF triplet proteins in 
amyloid-beta plaques that are associated with dystrophic neurites (DNs). 
Recently, it has been shown that the deletion of NFL in the APP/PS1 mouse 
model contributes to DN pathology and amyloid-beta deposition, as well as 
microgliosis and synapse degradation (Fernandez-Martos, King et al. 2015). 
Moreover, Cdk-5 a ser/thr proline-directed kinase that Pin1 directly acts upon, 
interacts with neurofilaments in order to regulate and dynamically control axonal 
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cytoskeletal outgrowth important to synapse formation and dendritic plasticity 
(Kesavapany, Li et al. 2003). Neurofilament health and functionality is a vital 
component to a functionally healthy neuron. In the present study, it is shown that 
at 12 months, NFL is 2.1-fold higher in the Pin1 treated mice than the GFP 
control mice, indicating that Pin1 may be playing a protective role through direct 
action or indirect Cdk-5 modulation. We posit that the upregulation of Pin1 in this 
instance is potentially preserving some synaptic functionality and dendritic 
plasticity over that of GFP control, though further analysis is needed to confirm. 
 
Immunity related GTPase family Q protein (IRG-Q) is part of a family of proteins 
that comprise of an early immune response and, in most cases, a result leading 
to the clearance of pathogens. In the current study, IRG-Q was found to be 3.3-
fold increase in the Pin1 overexpressed mice than that of GFP mice. It would be 
tempting to say that the vector used to deliver the Pin1 overexpression may have 
caused this increase, though it is not seen nearly as high in the GFP control 
group which used the same vector for overexpression; therefore, it can be 
concluded that this increase in IRG-Q is a result of pin1 overexpression itself. 
Pin1 has been known to function in the immune response and diseases that 
affect the immune system from the regulation of HIV-1 lifecycle, to interaction 
with Toll-like receptors and their downstream signaling effects (Tun-Kyi, Finn et 
al. 2011, Hou, Wang et al. 2015). With regards to the current study, it has been 
found that loss of Irg1 results in the activation of effector proteins that damage 
lysosomal function (Maric-Biresev, Hunn et al. 2016). Further evidence suggests 
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that Irg’s affect autophagy and proteasome function through association with 
Atg5 and Atg8 (Haldar, Piro et al. 2014). Upregulation of Irg protein levels may 
indicate an attempt by the cell to focus on the clearing of amyloid beta from the 
cell by way of autophagy and the ubiquitin proteasome. 
 
Phosphatidylethanolamine-binding protein 1 (PEBP1), also known as Raf kinase 
inhibitor protein (RKIP) is part of a highly conserved signaling family of proteins 
that are involved predominantly in the cellular cycle and in brain development 
(Vallee, Coadou et al. 2003). RKIP is intricately involved in the MAP kinase and 
NF-kappaB pathways through the interaction of MEK and Raf-1 inhibition and 
TAK1, NIK, IKK-alpha/beta inhibition, respectively (Yeung, Rose et al. 2001, 
Corbit, Trakul et al. 2003). Antagonism of the NF-kappaB pathway would provide 
a means for the cell to decrease inflammatory response, neuro-inflammation 
being an important hallmark of AD progression (Alam, Alam et al. 2016). Here, 
we show that RKIP is 98.6-fold increased in the Pin1 overexpressed mice when 
compared to the GFP mice. RKIP has also been found to associate with and 
activate choline acetyl transferase (ChAT), which creates acetylcholine (Sun, Luo 
et al. 2013). Acetylcholine is a neurotransmitter found to have low levels in the 
synapses of frontal cortex in Alzheimer disease patients. In order to correct for 
this, acetylcholine esterase inhibitors were used to combat the symptoms of AD 
with limited success (Mendiola-Precoma, Berumen et al. 2016). Through RKIP 
overexpression, it appears that the cell may be attempting to rectify this situation 
through activation of ChAT though acetylcholine levels should be checked in the 
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future to verify this notion. 
 
Myc box-dependent-interacting protein 1 (BIN1) is a nuclear localized isoform of 
amphiphysin 2 initially shown to interact with myc to suppress its tumor 
promoting effects (Sakamuro, Elliott et al. 1996). Early drosophila studies 
demonstrate that amphiphysin isoforms localize in membrane domains 
undergoing drastic changes in cell curvature or surface area expansion, thus its 
role in actin cytoskeleton integrity was confirmed (Zhang and Zelhof 2002). More 
recently however, amphiphysin isoforms have been described in the trafficking of 
vesicles and endosome budding events for intracellular trafficking through its 
interaction with SNX4, a process of great importance to all cell types, but brain 
tissue in particular (Zhang and Zelhof 2002). SNX molecules have been 
implicated in the association with transmembrane receptors such as EGF, insulin 
receptors, leptin receptors, and PDGF, and is suspected to be complicit in the 
selection of vesicular cargo or the budding event in particular. Much more 
recently, it has been shown that Bin1 loss and dysfunction raise amyloid-beta 
generation through the increase in APP and BACE1 interaction in early 
endosomes (Ubelmann, Burrinha et al. 2016). The APP and BACE1 now trapped 
in dysfunctional endosomes may no longer be recycled in the axon and continue 
to produce amyloid-beta which are not able to be cleared to lysosomes 
(Ubelmann, Burrinha et al. 2016).  In the present study, we have shown BIN1 to 
be increased 1.9-fold in the Pin1 overexpressed mice as compared to control, 
though this finding is not statistically significant (p=0.09) due to a large standard 
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deviation among samples. It was included, however, due to the fact that near 
significance was obtained and this protein plays a vital role in a process known to 
go awry in neurodegenerative diseases such as AD. AD is plagued with not only 
synaptic vesicle dysfunction, but also intracellular trafficking dysfunction due to 
aberrant endosomal trafficking. We posit that increased Bin1 in the Pin1 mice 
represent an attempt to rescue early endosome function to prevent amyloid-beta 
propagation and endosomal obstruction. 
 
Another protein intricately involved in cell structure and integrity is actin-related 
protein 3 (ARP3) which when in combination with seven other proteins, 
comprises of the ARP2/3 complex involved in the nucleation of actin filaments 
(Pollard, Blanchoin et al. 2000). Moreover, ARP2/3 complex binds to already 
existing actin networks in order to catalyze the formation of branched filaments, a 
vital component of the dendritic nucleation model (Pollard, Blanchoin et al. 2001). 
In regards to the neuronal axonal growth cone, ARP2/3 is a vital component to 
plasticity and works in conjunction with cofilin to provide properly functioning 
neuronal networks, an area severely and detrimentally impacted in AD (Dumpich, 
Mannherz et al. 2015, Jang and Chung 2016). Within the current study, ARP3 
has been shown to be 2.1-fold (p=0.056) increased in the Pin1 overexpressed 
group over that of the GFP control. An increase in ARP3 may represent an 
attempt by the cell to maintain control over its axonal growth cone and neuronal 
plasticity in order to protect the functional synapses that remain in AD state, 
considering that the ARP2/3 complex is highly associated with synaptic plasticity 
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as it has been found to be present in dendritic formation and synaptic integrity 
and the axonal growth cone (Dumpich, Mannherz et al. 2015). Since synaptic 
degradation and axonal/dendritic shortening is known to occur in AD, any attempt 
to mitigate this damage would potentially serve to protect the brain from further 
degeneration (Mitsuyama, Futatsugi et al. 2009). 
 
D-dopachrome decarboxylase (tautomerase) D-DT is an cytokine that is related 
to the macrophage migration inhibitory factor (MIF) super-family of proteins, in 
both sequence and catalytic activity (Honigman, DiGregorio et al. 2012). MIF 
proteins are generally described pro-inflammatory cytokines with control over the 
innate and adaptive immune response, with specific activation of the MAP kinase 
cascade and interestingly, as an immunosuppressive agent against 
glucocorticoids and in some cell types acts as a survival or anti-apoptotic protein 
factor (Merk, Mitchell et al. 2012).  D-DT binds MIF cell surface receptor complex 
CD74/CD44 where it proceeds to act as an effector for cell signaling activity. It 
has been shown that neutralization of MIF/D-DT in vivo decrease inflammation 
and improves outcome in some animal models of disease, where MIF/D-DT have 
been found to be elevated (Merk, Mitchell et al. 2012). Here, we find that D-DT is 
increased 1.9-fold in the Pin1 upregulated mice in comparison to that of the GFP 
controls. This upregulation of this newly described cytokine could be indicative of 
a cellular response initiated to combat inflammation described in AD models, and 
potentially to prevent loss of brain tissue through necrotic or apoptotic means 




Growth factor receptor-bound protein 2 (Grb2), is required for nearly all receptor 
tyrosine kinase signaling cascades, and was first described in the MAPK 
pathway as a mediator between MAPK and the epidermal growth factor receptor 
(EGFR) (Belov and Mohammadi 2012). Grb2 itself lacks most canonical 
enzymatic functions, but instead relies on its physical association with receptor 
SH2 domains to recruit further effector proteins to localized regions for signal 
transduction. Because of the ubiquity of Grb2 in RTK singal transduction, it is 
difficult without extensive signaling workups to determine the effect in these 
samples of an upregulated Grb2. Here we find that Grb2 is 2.1-fold increase in 
the Pin1 overexpressed mice as opposed to the GFP controls. Grb2 association 
is linked to the activation of the Ras-MAPK and PI3-Akt pathways (Boriack-
Sjodin, Margarit et al. 1998). Both pathways are pro-survival pathways indicating 
that the observed increase in Grb2 could potentially be associated with the cell 
attempting to preserve itself. Moreover, Grb2 has been implicated as not only a 
docking protein, but also a trafficking protein. In an AD-like model, it has been 
shown that Grb2 interacts with the AICD of APP and co-localized in mature 
autophagasomes, indicating that Grb2 may be working to effectively clear APP in 
a healthy cell, and that the upregulation of Grb2 in the current study may indicate 
that the brain is working to prevent amyloid buildup through the degradation of 
the precursor or AICD remnants (Roy, Chakrabarti et al. 2014). 
 
Energy production is an area severely impacted by AD as shown in PET imaging 
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of Alzheimer brain (Zippo and Castiglioni 2016). Our laboratory, and others, have 
shown numerous energy related proteins to be either deficient in level or 
oxidatively damaged throughout the disease progression (Butterfield, Hardas et 
al. 2010). One such protein is glycerol-3-phosphate dehydrogenase (GPDH), a 
lesser known enzyme involved in metabolism and lipid synthesis that links 
respiration to synthesis. At its most basic function, GPDH oxidizes glycerol-3-
phosphate (the alcohol version of glyceraldehyde-3-phosphate) to 
dihydroxyacetone phosphate (DAP), a glycolytic intermediate, using an FADH2 
electron transfer intermediate for reduction (Mracek, Drahota et al. 2013). GPDH 
is highly specific to tissue type (presenting mostly in brown adipose tissue, 
muscle, and brain) and its expression is suppressed in most tissue types and 
varies with energy demands (Benard, Faustin et al. 2006). Moreover, GPDH 
functions as an important step in the glycerophosphate shuttle which links 
glycolysis to fatty acid oxidation and oxidative phosphorylation (Green, Needham 
et al. 1937). Interestingly however, the upregulation of GPDH may be a double-
edged sword, in that the cell may benefit from increased or more efficient energy 
production and lipid synthesis, but at the cost of increased ROS production due 
to the Flavin dependent electron transfer intrinsic to GPDH (Mracek, Drahota et 
al. 2013). Here, we show that GPDH levels are 2.1-fold (p=0.05) that of the GFP 
controls when Pin1 levels are increased. This result could possibly be indicative 
of an attempt by the cell to recover control over energy production though in 





Carbonic anhydrase is a zinc metalloenzyme which functions to catalyze the 
reversible hydration of carbon dioxide to bicarbonate, mutations of which in the 
brain may cause cerebral calcifications and is often a contributor to mental 
deficiencies (McMahon, Will et al. 2001, Kida, Palminiello et al. 2006). Carbonic 
anhydrase also functions through the interaction with Na+/H+ exchanger, 
substituting intracellular proton for an extracellular sodium ion (Counillon and 
Pouyssegur 2000). Through this interaction along with its named function, 
carbonic anhydrase II expands its function to that of pH equilibrium, 
gluconeogenesis, lipogenesis, bone resorption and calcification, and 
cerebrospinal fluid formation (Kida, Palminiello et al. 2006). It was shown that in 
developing human brain deficient of carbonic anhydrase II, cerebral calcifications 
could be detected using computed tomography scanning within the sulci and in 
the putamen and caudate (Cumming and Ohlsson 1985). Here, carbonic 
anhydrase II is shown to be 3.5-fold higher (p=0.004) in the Pin1 overexpressed 
mice than that of the GFP mice. This increase in brain carbonic anhydrase II may 
play a vital role in overall brain homeostasis maintenance with regards to cellular 
pH, of which contributes to redox status as well as maintaining the common 
theme of metabolic control, a well-known and common theme of dysfunction 
throughout the progression of AD. 
 
Cofilin-1 is a main actin regulatory protein which governs much of the dynamic 
nature of the cytoskeleton. Actin dynamics is dramatically important in neuron 
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and brain tissue health due to the directionality inherent in brain tissue cells. 
Cofilin-1 dysregulation has been implicated in a number of neurodegenerative 
disorders such as AD, Parkinson’s disease, and Huntington’s disease 
(Schonhofen, de Medeiros et al. 2014, Bamburg and Bernstein 2016). Together 
with actin depolymerizing factor (ADF), cofilin mediates the rapid assembly or 
disassembly of actin which in turn allows for increased neuronal plasticity, 
important for normal brain function and a detrimental loss in neurodegenerative 
diseases like AD. Cofilin, however, is also a prime target for oxidation given 
cofilin contains four free sulfhydryl groups that are easily oxidized in stressed 
cellular environments which induces the formation of actin rod formation 
(Pfannstiel, Cyrklaff et al. 2001). Damaged cofilin associates with bundled rods 
and is hypothesized to be a detriment to amyloid-beta clearance to lysosomes in 
the early stages of AD (Bamburg, Bernstein et al. 2010). Here, we show that 
Cofilin-1 is reduced 0.51-fold (p=0.35* Ttest with high standard deviation) in the 
Pin1 treated mice as opposed to that of the GFP treated mice. It is not clear if 
this possible cofilin-1 reduction is due to association with rod-formation, similarly 
to how Pin1 is lost in NFT, or if cofilin is being reduced in expression through 
Pin1 overexpression, though future studies could elucidate this connection. While 
decreased cofilin could potentially cause a loss of synaptic plasticity, it is also 
possible that cofilin is being decreased in order to prevent rod formation, though 
these are only speculations that need clarification. This cofilin interaction also 
could be important due to the increased expression of ARP2/3 found within the 
current study, since both are highly associated with synaptic plasticity and 
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In conclusion, expression proteomics of Pin1 overexpression in AD model mice 
resulted in a number of key proteins being identified as presenting with altered 
levels which may aid in elucidating future areas for research into the role of Pin1 
in AD progression. A common theme amongst the proteins identified was 
structural integrity and plasticity, along with signaling events that appear to be 
aimed at cell survival and proper endocytic trafficking and clearance. These 
results shed new light on the role of Pin1 in a stressed cell, and future research 










CHAPTER 4: INTRANASAL INSULIN ADMINISTRATION IN MOUSE MODELS 
OF ALZHEIMER DISEASE AND INDUCED DIABETES: OXIDATIVE STRESS 


















4.1 OVERVIEW OF STUDY 
Intranasal Insulin administration given to AD (APP/PS1) and induced diabetes 
(dbdb) mice, and the cross between the two (dbdbxAPP/PS1), to determine the 
effects of intranasal insulin on global oxidative stress measurements and 
changes to the proteome with respect to treatment and genotype. Using 
immunochemistry it was found that protein carbonyls were slightly, but 
statistically significantly, decreased in the APP/PS1 and dbdbxAPP/PS1 mice by 
approximately 9% in both groups. Expression proteomics was then employed to 
determine the changes to the proteome between treatments and genotype and 
uncovered a number of proteins important to different cellular processes such as 
cellular signaling, structure, and metabolism.  
4.2 INTRODUCTION: 
The brain relies predominantly on its ability to quickly utilize glucose for the vast 
majority of its energy needs. The brain is a highly metabolic organ, which, while 
only comprising just about 2% of the average body weight of a human, utilizes 
approximately 30% of the oxygen and 20% of the glucose intakes to meet the 
brain’s energy requirements. The loss of normal glucose metabolism in AD 
patients has been demonstrated using PET imaging as previously discussed (de 
Leon, George et al. 1983, Jack, Petersen et al. 1999).  The loss of glucose 
utilization may be due to either the inability to uptake glucose from the circulatory 
system or a loss of the ability to properly metabolically process the glucose within 
the cells of the brain. Evidence has shown that both of these possibilities have 
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merit (Frolich, Blum-Degen et al. 1998, Hoyer 2004, Butterfield and Lange 2009, 
Butterfield, Galvan et al. 2010). More to the point, AD and insulin resistance 
diseases share a number of commonalities such as increased oxidative stress, 
cytokine activation, mitochondrial dysfunction, reduced insulin-stimulated growth 
and survival, deficits in metabolic activity, and activation of the mammalian target 
of rapamycin (mTOR) with consequent deleterious inhibition of autophagy (de la 
Monte, Re et al. 2012, Li, Han et al. 2015, Tramutola, Triplett et al. 2015). 
The peptide hormone insulin plays a major role in the energy homeostasis of the 
body, regulating the uptake of circulating glucose for cellular utilization. 
Specifically within the brain, insulin and the insulin-like growth factor 1 (IGF-1) 
promote growth, survival, gene and protein expression, neurotransmitter 
functionality, neuronal plasticity and synapse formation, and metabolism within 
neurons and glia (de la Monte and Wands 2005, Joseph D'Ercole and Ye 2008). 
Prolonged insulin resistance has been demonstrated to lead to increased plasma 
lipids, hypertension, and a chronic loss of cellular energy (Dankner, Chetrit et al. 
2009), which are likely to lead to the observed effects of the aforementioned PET 
studies. In fact, while the genes for IGF-1/2 and insulin receptors are expressed 
in both neurons and glia throughout the brain, both are reported to be particularly 
dense in areas found to be affected by AD and other neurodegenerative 
disorders indicating that these areas important for memory and cognition are 
likely more reliant on glucose and insulin signaling (de la Monte and Wands 
2005, de la Monte, Longato et al. 2009, de la Monte and Tong 2014). 
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Poor glucose uptake by the brain likely results from systemic insulin resistance 
resulting from prolonged states of hyperinsulinemia that accompanies 
hyperglycemia, a state of high blood sugar that often times is associated with, or 
a contributor to, obesity. Obesity not only leads to insulin resistance but also 
significantly increases the risk for type-II diabetes mellitus (T2DM), metabolic 
syndrome, and cognitive dysfunction (de la Monte and Wands 2008, Lyn-Cook, 
Lawton et al. 2009, de la Monte and Tong 2014). In fact, obese patients 
demonstrate impairments in executive function as well as a two-fold increased 
risk of developing AD compared to a healthy individual (Gunstad, Paul et al. 
2007, Yaffe 2007). The increased glucose intolerance and insulin resistance 
associated with obesity increase the risk of MCI and AD, themselves (Gunstad, 
Paul et al. 2007, Lokken, Boeka et al. 2009). 
Insulin delivery via the intranasal route has been the focus of research due to the 
indirect pathway to the brain through uptake into the olfactory nerve. The delivery 
of drugs to the brain through the intranasal route is advantageous in comparison 
to more traditional approaches such as intraperitoneal (IP) injection or oral 
administration due to the ability to bypass the blood brain barrier (BBB), a major 
obstacle in delivery therapeutics directly to the brain, using a non-invasive 
procedure. Moreover, avoidance of insulin-dependent shock is avoided by by-
passing the peripheral system for insulin delivery. Coupled with the finding that 
nasal mucosa both express and deliver insulin to the brain with a normal 
functioning neuroanatomical link between the olfactory and limbic system in 
which both memory and cognitive function participate, intranasal insulin as a 
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therapeutic for neurodegeneration was a logical target for investigation (Hanson 
and Frey 2008). Indeed, intranasal insulin already has been shown to improve 
cognitive function related to attention and verbal and hippocampal declarative 
memory (Messier and Teutenberg 2005, Benedict, Hallschmid et al. 2007, 
Benedict, Frey et al. 2011). Following INI, both memory and metabolic function in 
MCI and AD subjects were improved; however those that were APO-ε4 positive 
were shown to perform poorly on recall tasks compared to those that were APO-
ε4 negative (Reger, Watson et al. 2006, Reger, Watson et al. 2008). From a 
mechanistic point of view, insulin has been shown to increase the clearance of 
amyloid from the brain, inhibit the activity of tau phosphorylating kinases, and 
support neuronal cytoskeletal and cholinergic functions (de la Monte and Wands 
2005, Reger, Watson et al. 2008, Schioth, Craft et al. 2012). However, more 
research is needed in order to better understand the complex changes and 
function of the proteome that occur in both Alzheimer and diabetic models with 
the application of intranasal insulin. Here, we have used a combination of 
Alzheimer and diabetic mouse models to determine the effects of intranasal 
insulin administration on the formation of protein carbonyls, a common protein 
oxidation marker, and the expression of downstream proteins in order to better 





4.3 MATERIALS AND METHODS 
4.3.1 MATERIALS 
All chemicals used in these experiments were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) with some exceptions: Criterion precast polyacrylamide gels, 
ReadyStripTM IPG strips (pH 3-10), Precision Plus ProteinTM All Blue Standards, 
Sypro Ruby® Protein Stain, MOPS and TGS running buffers, mineral oil, 0.2 nm 
nitrocellulose membrane, idodoacetamide (IA), dithiothreitol (DTT), biolytes, and 
urea which were purchased from Bio-Rad (Hercules, CA, USA). Modified trypsin 
solution was obtained from Promega (Madison, WI, USA) and the C18 ZipTips 
were bought from Millipore (Billerica, MA, USA). Amersham ECL IgG horseradish 
peroxidase-linked secondary antibodies and ECL-Plus Western blotting 
chemiluminescent detection reagents were purchased from GE Healthcare 
(Pittsburgh, PA, USA). 
4.3.2 ANIMALS 
The mouse models used in this experiment were genotyped and obtained from 
the Michael P. Murphy laboratory at the University of Kentucky, Lexington KY. 
For use in the experiments performed, four distinct mouse models were used: 
C57BL/6 were used as the Wild Type (WT), APPΔNL/ΔNL/PS1P264L/P264L (APP/PS1) 
were used as the AD model, db/db were used as the induced diabetic model, and 
a cross between the db/db and the APP/PS1 (db/dbxAPP/PS1) were used as a 
diabetic-Alzheimer model. The mice were housed in an AALAC-approved animal 
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facility with a 12-hour light-dark cycle and fed the standard rodent chow ad 
libitum. Prior to any experiment involving the use of animal models, University of 
Kentucky (UK) IACUC approval was obtained and all work herein was performed 
in accordance with all federal specifications. 
All animals were subjected to IACUC approved wellness checks regularly and 
throughout the duration of the study timeframe. Any animal deemed unfit to 
continue the study due to perceived suffering was immediately euthanized. 
All mice began treatment at 8 months of age and continued for two months until 
the age of 10 months, where they were euthanized with slow introduction of 
carbon dioxide followed by decapitation. Brain tissue was immediately harvested, 
flash frozen in liquid nitrogen, and stored at 80 ͦC until use.  
4.3.3 INTRANASAL INSULIN ADMINISTRATION 
At 8 months of age, each mouse genotype wad divided into two groups (n=4) and 
the mice were randomly assigned to either insulin or saline. Three times weekly, 
the mice were administered via intra-nasal route 24 µL of either 0.86 units insulin 
in 0.06% saline solution or 0.06% saline solution divided over four 6 µL aliquots 
with 30 seconds in between administrations. If mice appeared to struggle with an 
administration, they were allowed additional time to recuperate before the next 
administration. If the mice exhaled the solution, or coughed it up after 
administration, another administration was given after an appropriate amount of 
time to allow the mouse to recuperate. The administrations continued for two 
74 
 
months where the mice were then euthanized according to the procedures 
previously mentioned. 
4.3.4 SAMPLE PREPARATION 
The brains from the m ice were thawed and individual homogenates were 
prepared using a wheaton glass homogenizer (approximately 40-45 passes) with 
ice-cold isolation buffer [0.32M sucrose, 2mM EDTA, 2mM EGTA, 20mM HEPES 
buffer, 0.2µg/ml PMSF, 4µg/ml leupeptin, 4 µg/ml pepstatin, 5µg/ml aprotinin]. 
Homogenates were subsequently vortexed followed by sonication on ice for 10s 
at 20% power, two times, allowing the sample to rest 20s on ice between 
vortexings, with a Fisher 550 Sonic Dismembrator (Pittsburgh, PA, USA). 
Concentration of the protein in the homogenates was determined by the Pierce 
BCA method (Rockford, IL, USA). 
4.3.5 PROTEIN CARBONYL SLOT BLOT 
To determine the level of protein carbonyl to obtain an index of oxidative stress in 
each sample, slot blot analysis was performed using the Bio-Dot SF 48-well (slot 
format) apparatus obtained from Bio-Rad (Hercules, CA, USA). Prepared 
samples (5 µL) were pipetted into a micro centrifuge tube followed by the addition 
of 5 µL of 12% SDS solution. 2,4-dinitrophenylhydrazine (DNPH) in 2N HCL (10 
µL of 10 mM) was added to each sample and incubated for a total of 20 min at 
room temperature (RT) to allow derivativization. After 20 min incubation, the 
samples were neutralized with 7.5 µL of 2M Tris in 30% glycerol and diluted to 
100 µL with 1x PBS. Samples (250 ng) were loaded into each well onto a 
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nitrocellulose membrane within the slot-blot apparatus and a vauum suction 
applied. The membrane was removed and blocked with a blocking solution [3% 
bovine serum albumin (BSA) in TBS + Tween (TBS+T)] for 1.5 hours. 
Membranes were incubated with rabbit polyclonal anti-DNP antibody (1:100 
dilution, OxyBlotTM Protein Oxidation Detection Kit) for 2 hours at RT. The blot 
was then washed 3 times, 5 min each, with TBS+T and then incubated with 
alkaline phosphatase-conjugated goat anti-rabbit secondary antibody (1:5000; 
Sigma Aldrich, St. Louis, MO) for 1h at RT. Membranes were washed 3 times (5 
min, 10 min, 10 min) followed by developing with 5-bromo-4-chloro-3-indolyl-
phosphate/nitroblue tetrazolium (BCIP/NBT) color developing reagent for alkaline 
phosphatase activity (Sigma Aldrich). Blots were subsequently dried and 
scanned using a Bio-Rad ChemiDocTM XRS+ imaging system and quantified with 
Image LabTM software (Bio-Rad, Hercules, CA, USA). 
 
4.3.6 TWO-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS 
(2D-PAGE) 
4.3.6.1 ISO-ELECTRIC FOCUSING 
Brian tissue homogenates (200 µg) from the various mouse models were shaken 
in 200 µl of rehydration buffer [8M urea, 2.0% (w/v) CHAPS, 2 M thiourea, 50 mM 
dithiothreitol (DTT), 0.2% biolytes, 0.01% bromophenol blue] for 1.5 hr at RT 
followed by sonication for 10 s at 20% power. The sonicated samples were 
applied to 11 cm pH 3-10 ReadyStripTM IPG strips with a linear gradient. The IPG 
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strips were actively rehydrated at 20°C for 18 h at 50 V utilizing a Bio-Rad 
Protean IEF Cell (Hercules, CA, USA). After 60 min, 2 mL of mineral oil was 
added to the strips to prevent dehydration. Subsequently, isoelectric focusing 
was performed at a constant temperature of 20 °C starting at 300 V for 2 h, 500 
V for 2 h, 1000 V for 2 h, 8000 V for 8 h, and finishing at 8000 V for 10H. The 
IPG strips were then removed upon completion and stored at -80°C immediately 
following removal and stored until future use. 
4.3.6.2 SDS PAGE 
IPG strips were thawed 10 min followed by 4 ml of a DTT-containing equilibration 
buffer [50 mM Tris-HCl, pH 6.8, 6 M urea, 1% (w/v) SDS, 30% v/v glycerol, 0.5% 
DTT] for 10 minutes in the absence of light. The strips were removed from 
solution and placed in clean wells where 4 mL of an iodoacetamide-containing 
buffer [50 mM Tris-HCl, pH 6.8, 6 M Urea, 1% (w/v) SDS, 30% v/v glycerol, 4.5% 
iodoacetamide] was added, again in the absence of light. The IPG strips were 
rinsed in a 1x dilution of TGS running buffer and placed into Criterion precast 
linear gradient (8-16%) Tris-HCl polyacrylamide unstained gels. Precision Plus 
ProteinTM All Blue molecular weight marker was added and agarose gel was 
overlaid. Gels were run at a constant voltage of 200 V for approximately 60 min 
using 1x Tris/Glycine/SDS running buffer. 
4.3.6.3 IMAGE ANALYSIS 
Spot intensities of the imaged unstained gels were quantified by densitometry 
using PDQuest 2-D Analysis Software (Bio-Rad, Hercules, CA, USA). Individual 
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gel spot intensities were normalized to the total density of the individual gel. Spot 
densities from the eight experimental groups (WT(s), WT(i), APP/PS1(s), 
APP/PS1(i), db/db(s), db/db(i), db/db x APP/PS1(s), and dbdb x APP/PS1(i)) 
were compared and the spots with a statistically significant difference based on 
two-way ANOVA and Bonferonni multiple comparisons were considered for in-gel 
trypsin digestion and identification of the protein of interest. 
4.3.6.4 SYPRO RUBY STAINING 
Following 2D-PAGE, and PDQuest analysis, sample gels (Criterion precast linear 
gradient (9-16%) Tris-HCl polyacrylamide gels) were run rollowing the same 
procedure but fixed in solution [7% (v/v) acetic acid, 10% (v/v) methanol] (50 mL) 
for 45 min at RT on a gently orbiting platform. After fixing, the solution was 
removed and 50 mL of Sypro Ruby® Protein Gel Stain was added to stain 
proteins in the gel overnight (15 h) at RT with gentle orbiting. Gels were rinsed 
and transferred to 50 mL of deionized water at RT until scanning. The Gels were 
scanned utilizing a Bio-Rad ChemiDocTM XRS+ imaging system (Hercules, CA) 
and subsequently stored in deionized water at 4°C until extraction of protein 
spots. 
4.3.6.5 IN-GEL TRYPSIN DIGESTION AND PEPTIDE EXTRACTION 
Protein spots were identified as significant using PDQuest software and excised 
from 2D-gels followed by transfer to Eppendorf micro-centrifuge tubes. 20 μL of 
0.1 M ammonium bicarbonate (NH4HCO3) were added to the tubes and allowed 
to incubate at RT for 15 min. Next, 30 μL of acetonitrile were added to each tube 
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and again, incubated at RT for 15 min. The solvent was removed and gel plugs 
allowed to dry at RT for 30 min. 30 μL of 20 mM DTT in 0.1 M ammonium 
bicarbonate was added to the gel plugs and incubated for 45 min at 56°C. 
Following the removal of the DTT/NH4HCO3 solution, 30 μL of 0.05 M 
iodoacetamide (IA) in 0.1 M NH4HCO3 were added and incubated at RT for 15 
min. The previous IA solution was removed and 150 μL  of 0.05 M NH4HCO3 
were added to incubate for 15 min at RT. 200 μL of acetonitrile (CAN) were then 
added to the solutions and incubated for another 15 min. Gel plugs were dried for 
30 min at RT before rehydrating with 10 μL of modified trypsin solution in 0.05 M 
NH4HCO3. Gel plugs were incubated at 37 °C and shaken at 230 RPMs 
overnight (15 hrs.). The resultant digest was transferred to Eppendorf tubes while 
20 μL of a 5% CAN, 0.1% formic acid (FA) solution was added to the old tube 
containing the gel plug and sonicated in a RT water-bath for 15 min. Following 
water-bath sonication, 30 μL of a 95% CAN, 0.1% FA and 0.001 M NH4HCO3 
solution were added and again water-bath sonicated for 15 min. The solution was 
removed from the gel plug tube and combined with the supernatant digest 
solution. Using a Speed-Vac, the digest solution samples were concentrated to a 
volume of 10 μL. C18 ZipTips were used to remove remaining salts and 
contaminants from the trypsin-digested peptide solution using the following 
procedure. 10 μL of 100% CAN were aspirated into the ZipTip and expelled 5 
times, followed by 10 μL of a 50% CAN solution containing 0.1% FA, which were 
aspirated and ejected 5 times. The trypsin digested solution was drawn up and 
pushed out of the column for a total of 10 times to allow for peptide adherence to 
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the column. Contaminants were eliminated from the peptides through the ZipTip 
by washing with 10 μL of a 5% CAN and 0.1% FA solution by aspirating and 
expelling the eluent 5 times and the eluent stored at -80 degrees Celsius. 
4.3.6.6 NANOLC-MS WITH DATA DEPENDENT SCAN 
The samples described above were analyzed by a nanoAcquity (Waters, Milford, 
MA)-LTQ Orbitrap XL (Thermo Scientific, San Jose, CA) system in a data-
dependent scan mode. An in-house packed capillary column (0.1 x 130 mm 
column packed with 3.6 μm, 200 angstrom XB-C18) with a gradient with 0.1% FA 
and CAN/0.1% FA at 200 nL/min were used for separation. The MS spectra were 
acquired using an orbitrap at 30,000 resolution and MS/MS spectra of the six 
most intense ions in the MS scan were attained by the orbitrap at 7,500 
resolution. Subsequently, files from the samples were searched against the most 
current version of the Swiss-Prot database by SEQUEST (Proteome Discoverer 
v1.4, Thermo Scientific). A minimum of two high-confidence peptide matches are 
required for protein identification (with a false discovery rate <1%). Proteins that 
are matched with the same peptides are reported as one protein group. 
Resultant MS/MS data were first verified by a comparison of the expected 
molecular weight and isoelectric point of the identified protein to that of the 
extracted plug from the 2-D gel. 
4.3.7 STATISTICAL ANALYSIS 
An ANOVA was performed followed by a Bonferroni correction for multiple 
comparisons in order to determine the effects of intranasal insulin administration 
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in Alzheimer and diabetic mouse models on the expression of proteins within the 
tissue of the brain. An α<0.05 was selected as a measure of significance for the 
ANOVA while a p<0.05 was selected as a measure of significance for the 
multiple comparisons test. Fold-change values of any differentially expressed 
proteins were determined by dividing the average spot intensity of the gels from 
the Insulin groups by the average spot intensity of the gels of the saline group, or 
to whichever group the comparison was being made for the individual protein 
found to be differentially expressed. Proteins that were identified by the 
SEQUEST search algorithm with p<0.01 were considered to be statistically 
significant. To further validate MS/MS identification of significant differentially 
expressed proteins, the position of protein spots on the 2D-gel images were 
manually examined to confirm that they were located near the expected 




4.4.1 SLOT BLOT ANALYSIS 
Protein carbonyl slot blots were performed on each group in order to determine 
the effect of intranasal insulin administration on the formation of brain protein 
carbonyls. In the wild-type group, there was no statistical difference between 
insulin and saline administrations (Insulin: 100.06% of control; p=0.9). The 
dbdbxWT/WT group showed a trend toward a decrease in protein carbonyls, yet 
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was not statistically significant. The APP/PS1 group displayed a significant 
decrease in protein carbonyls by 8.1% (p<0.05) with intranasal insulin 
administration, while the dbdbxAPP/PS1 group showed a significant decrease in 
protein carbonyls by 9.2% (p<0.002) following insulin administration. 
 
Figure 4.4.1a: Representative dbdbxAPP/PS1 Insulin vs Saline Protein Carbonyl 





Figure4.4.1b: Representative dbdbxAPP/PS1 Insulin vs Saline Protein Carbonyl 
(Trial 2) Slot Blot 
 


















































































Figure 4.4.1f: APP/PS1 Protein Carbonyl Trial 2 Slot Blot 
 
4.4.2 EXPRESSION PROTEOMICS ANALYSIS 
Proteomic analysis of the proteins of the insulin vs saline groups were conducted 
using a 2D-PAGE approach with Sypro Ruby staining. Protein spot intensities 
were compared between these four groups to determine differentially expressed 
proteins. Figure shows representative examples of 2-D gel images of the isolated 
proteins from the brain of the diabetic/Alzheimer mouse models given intranasal 
insulin administration with the 9 labeled proteins that were found to be significant 
differentially expressed. Figure shows representative examples of protein 
























diabetic/Alzheimer mouse models as a function of intranasal insulin 
administration and with the 9 labeled proteins that were found to be significant 
differentially expressed. In total, PDQuest analysis of all 8 groups of the 2-D 
images found 9 protein spots suitable for extraction and whose expression or 
oxidation was significantly altered in the brain. Protein spot extraction was 
followed by in-gel trypsin digestion, peptide extraction, removal of metal ions with 
buffers, and MS/MS analysis coupled to interrogation of protein databases to 
determine the identity of the differentially expressed proteins.  
 
Table 4.4.2 lists the 9 proteins that were found to be significant differentially 
expressed in the brain of the Alzheimer and diabetic mouse models given 
intranasal insulin or saline administration. These data provide added information 
such as: the spot number as labeled by the PDQuest program, the SwissProt 
accession number, percentage of the protein sequence covered by matching 
peptides, the number peptide sequences identified by the tandem mass 
spectrometry (MS/MS) analysis, the protein confidence score, the expected 
molecular weight and isoelectric point of the identified protein, as well as the fold-
change levels and p-values obtained from the PDQuest analysis. Fold-change 
values were calculated by dividing the average spot intensity of the gel protein 
spots of the dbdbXWT/WT, WTxAPP/PS1, and dbdbxAPP/PS1 by the average 
spot intensity of the WT/WT/WT gel spots. To expound, a fold increase of 1.75 in 
the dbdbxWT/WT group represents a 75% increase in protein expression of the 
dbdbxWT/WT group compared to the group used as a control in the comparison. 
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Moreover, a fold value less than 1, denotes a decrease in protein expression, for 
example a fold of 0.5 represents a decreased protein expression of 50%.  
 
As shown in Tables 4.4.2, all proteins (hereby referred to by shortened 
accronyms of DbAPP (dbdbxAPP/PS1), Db (dbdb), APP (APP/PS1), and WT all 
with either a suffix i or s as pertaining to their treatment group) were identified by 
more than one peptide sequence. Further, proteins that were identified by 
MS/MS analysis were preliminary validated by visually comparing the expected 
molecular weight and isoelectric point provided by Sequest software to the 
position of extracted protein spot on the gel. ATP synthase subunit d, 
mitochondrial:2113 (↑0.146-fold, p=0.01, APPi v APPs), Synaptosomal-
associated protein-25:2213 (↓0.0259-fold, p=0.0006, DbAPPi v Dbi; ↓0.0332-fold, 
p=0.0007, DbAPPs v Dbi; ↓0.0318-fold, p=0.0007, APPi v Dbi; ↓0.0273-fold, 
p=0.0007, APPs v Dbi; ↓0.0598-fold, 0.001, Wti v Dbi), Proteasome subunit alpha 
type-5:2307 (↓0.0325-fold, p=0.01, APPi v APPs), Transitional endoplasmic 
reticulum ATPase:2809 (↑5.7-fold, p=0.009, Dbi v Dbs; ↑3.55-fold, p=0.03, Dbi v 
APPi; ↑5.16-fold, p=0.01, Dbi v Wti), Stathmin:3001 (↑4.7-fold, p=0.02, Dbi v Dbs; 
↑5.12-fold, p=0.02, Dbi v APPi; ↑12.6-fold, p=0.002, Dbi v APPs), Growth factor 
receptor-bound protein 2:4207 (↑2.77-fold, p=0.01, DbAPPi v 
DbAPPs),Superoxide dismutase [Cu-Zn]:5002 (↓0.212-fold, p=0.02, DbAPPi v 
Dbi), Voltage-dependent anion-selective channel protein 1:5105 (↓0.102-fold, 
p=0.01, DbAPPi v DbAPPs), Hypoxanthine-guanine 
phosphoribosyltransferase:6102 (↑4.72-fold, p=0.01, DbAPPi v DbAPPs; ↑5.66-
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fold, p=0.008, DbAPPi v Dbi; ↑3.77-fold, p=0.02, DbAPPi v Dbs; ↑3.60-fold, 
p=0.03, DbAPPi v Wt). Table 4.4.2 lists the 9 significant differentially expressed 
proteins identified in the comparison of the Alzheimer and diabetic mouse models 





















Table 4.4.2: Proteins with altered expression in brain of dbdbxAPP/PS1, dbdb, 








Figure 4.4.2: Representative gels from the Insulin Study 
 
4.5 DISCUSSION OF RESULTS 
4.5.1 GLOBAL OXIDATIVE STRESS MEASUREMENTS 
First it was important to verify whether or not intranasal insulin administration had 
any significant impact on WT mice of any of the three oxidative stress measures 
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investigated. As can be seen in Appendix A, no significant changes in PC, HNE, 
and 3NT were observed in any measurement likely due to large internal standard 
deviations between mice, which will be discussed below. 
 
Protein carbonyls however were observed to be significantly reduced in the 
APP/PS1 mouse model despite a very modest 9% decrease (Figure 
4.4.1e;4.4.1f, p<0.05) . Both 3NT and HNE resulted in what appear to be a 
decreasing trend of 30% (p=0.17) and roughly 16% (p=0.13) respectively 
(Appendix A), but due to the variability between samples, the high standard 
deviation in the saline groups in particular was too large to overcome for 
significance despite acceptable sample variation, as seen in most cases. 
 
The diabetic dbdb group too fell victim to high sample variation and standard 
deviations despite, an acceptable confidence variable during blotting, resulting in 
no significant change in any redox modification parameter tested. However, the 
cross dbdbxAPP/PS1 model resulted in a very modest but statistically significant 
reduction in protein carbonyls at nearly 10% (Figure 4.4.1c p<0.02; Figure 4.4.1d 
p=0.068) while demonstrating no significant change in HNE or 3NT (Appendix A). 
Because the mice used in this experiment appeared to have such variation and a 
low sample size, those findings that were significant were repeated as can be 
seen above for dbdbxAPP/PS1 and APP/PS1 protein carbonyls. This data 
however, leaves much to be desired which could potentially be remedied by a 
larger sample size and perhaps a shorter duration of experiment, as an 
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unacceptable number of mice died during the two months of intranasal 
administration. Due to these premature deaths, a number of mice were culled 
from the study due to premature deaths either found in the cages or the result of 
stroke or heart attack during the intranasal administration process. While this 
data indicates that insulin may have been beneficial towards the reduction of 
protein carbonyls in the AD model mice, any further findings would require 
additional mice to further tease out additional effects and substantiate the 
findings of this experiment. 
 
4.5.2 EXPRESSION PROTEOMICS ANALYSIS 
Insulin signaling is a complex intracellular signaling cascade that has many 
downstream effects including energy regulation and transcription events (Thon, 
Hosoi et al. 2016). Therefore, insulin interaction with brain tissue should have far 
reaching downstream effects with regards to transcription and protein levels. 
Nine proteins were identified as having statistically significant altered protein 
levels in numerous comparisons in the utilization of two-way ANOVA method. 
Because of the nature of an experiment such as this, where multiple 
comparisons have to be made, many of the significant findings had to be 
excluded because they resulted in non-sense comparisons (i.e. Protein A being 
increased in the dbdb-insulin group over the APP/PS1-saline group). Through 
focusing only on interesting and valid comparisons, we narrowed our initial 
finding of approximately 76 statistically significant proteins down to nine through 
ANOVA. These nine proteins are implicated in a wide range of cellular functions 
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including energy production, synaptic transmission, oxidative stress mitigation 
and proteasome function, cellular signaling, and structural integrity. 
 
Energy and metabolic control are nearly synonymous with the word insulin in 
most cases, as blood glucose levels is what insulin was first known to regulate. 
ATP synthase, is the final enzymatic component to the long process of glycolytic 
energy production beginning with glucose and ending with reducing factors such 
as NADH being used to fuel a proton gradient that in turn mechanically rotates 
ATP synthase and aids in the production of most of the cellular ATP used for 
energy (Bernardi, Rasola et al. 2015). Here, we found that ATP synthase subunit 
d, mitochondrial, was significantly decreased in APPi v APPs comparison (0.146-
fold, p=0.01). Energy dysfunction is a common theme in both AD and diabetes, 
and ATP synthase is a common target of for differential expression (Tramutola, 
Lanzillotta et al. 2016). Decreased levels of ATP synthase could be reflective of a 
number of different causes, from decreased expression, to increased turnover or 
protein degradation, particularly since components of ATP synthase were 
identified by our laboratory using redox proteomics as being oxidatively modified 
(Butterfield, Perluigi et al. 2012). 
 
Synaptosomal-associated protein-25 (SNAP-25) is a t-snare protein and 
component of the SNARE complex which is thought to allow membrane adhesion 
and fusion of intracellular vesicles for exocytosis, as in neurotransmitter release 
into the synapse. In the current study, SNAP25 levels were drastically increased 
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in the dbdb-insulin group over nearly every other comparison (DbAPPi 0.0259-
fold, DbAPPs 0.0332-fold, APPi 0.318-fold, APPs 0.273-fold and WTi 0.0598-fold 
in comparison to DBi) other than the dbdb-saline (still increased, but not 
significant). This suggests that insulin in a diabetic mouse model not affected 
with AD pathology saw an increase in SNAP25 which may result in better 
synaptic transmission and communication. The Alzheimer models are likely not 
rescued from damage occurring to SNAP25, which could constitute a loss of 
protein level as opposed to solely an upregulation in the Dbi group as SNAP25, 
which is consistent with literature suggesting that SNAP25 levels are decreased 
and oxidatively modified in AD and other forms of dementia (Butterfield, Perluigi 
et al. 2012, Bereczki, Francis et al. 2016). 
 
The ability of the cell to effectively fold and process proteins during the 
production and trafficking process is vitally important, as misfolded or damaged 
proteins can cause aberrant functioning and even protein aggregation (Radwan, 
Wood et al. 2017).The proteasome is a vital component in the cell for both 
recycling cellular components, degrading damaged proteins, and degrading 
proteins that have been tagged with ubiquitin in order to stop their function as in 
the case of cell cycle proteins for example (Saeki 2017). In fact, E3-ubiqutin 
ligases play large roles in insulin resistance and diabetes through the 
degradation of important effector proteins and receptors (Yang, Xiang et al. 
2016). The cells responsibility for producing correctly folded proteins and dealing 
with misfolded proteins however is a complex process utilizing facets from 
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multiple cellular organs, including the endoplasmic reticulum where many 
proteins are first made and folded (Bhat, Chaudhary et al. 2016). The 
Transitional endoplasmic reticulum ATPase is necessary for the energy 
expenditure required by budding from the transitional endoplasmic reticulum 
(tER), which is an ATP-dependent process. tER-ATPase is required for the 
movement of unfolded or damaged proteins from the ER to the proteasome for 
degradation, and damage to this vital component possibly results in accumulation 
of damaged protein and a dysfunctional proteasome network (Zhang, Wang et al. 
2015). tER-ATPase was found in the current study to be increased in the Dbi v 
Dbs comparison (5.7-fold, p=0.009), Dbi v APPi (3.55-fold, p=0.03), and Dbi v 
Wti (5.16-fold, p=0.01), and proteasome subunit alpha type-5 is significantly 
decreased in the APPi v APPs (0.0325-fold, p=0.01) comparison. This drastic 
increase in the Dbi v Dbs group for tER-ATPase appears to indicate that insulin 
in the diabetic model has a much more pronounced effect whereas the 
introduction of AD pathology appears to have no real effect upon insulin 
administration. These results suggest that insulin signaling may play an important 
role in attempting to maintain a functional and efficient proteasome network in a 
diabetic model and not an AD model, as demonstrated by the diabetic model. 
However, due to the fact that that the DbAPP model does not show this change, 
reflects that the AD pathology may negate any positive change due to insulin in 
the diabetic part of the model. It is widely known that proteasome is deficient in 
AD resulting in abandoned endosomes propagating amyloid-beta production, 





Stathmin is a microtubule-destabilizing phosphoprotein. Stathmin functions by 
depolymerizing microtubules through the sequestering of free tubulin dimers, 
while also engaging in inducing microtubule-catastrophe (Gupta, Li et al. 2013). 
Microtubule dynamics and instability is paramount to a normally functioning cell, 
especially one that relies upon polarity and large scale endocytic trafficking such 
as neurons and other brain cells. Stathmin helps govern microtubule growth and 
shrinkage through the association with free tubulin, providing an indirect 
mechanism and means for endocytic transportation, mitochondrial recycling, and 
synaptic vesicle translocation (Gupta, Li et al. 2013). In the current study, 
Stathmin was found to be significantly increased in the Dbi v Dbs comparison 
(4.73-fold, p=0.01), Dbi v APPi (5.12-fold, p=0.02), and Dbi v APPs (12.6-fold, 
p=0.002). Our data suggest that the Alzheimer model with insulin administration 
does not receive the mitigating benefit to stathmin level that the diabetic group 
alone does, which is consistent with literature suggesting that stathmin is 
significantly decreased in AD brain (Jin, Masliah et al. 1996, Cheon, Fountoulakis 
et al. 2001). Moreover, there was no statistical difference between the DbAPPi v 
DbAPPs group which leads one to infer that the Alzheimer part of the model is 
responsible for the lack in Stathmin recovery. Cellular transport of vesicles and 
organelles is of the utmost importance for the maintenance of healthy neurons. 
AD, among others, is fraught with microtubule dysregulation as evidenced by 
NFT formation with protein tau, and evidence of vesicles that have failed to 
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merge with lysosomes found in early AD (Arendt, Stieler et al. 2016). 
 
Growth factor receptor-bound protein 2 (Grb2) interacts with nearly all receptor 
tyrosine kinases by way of their intracellular tail and SH2 domain interaction. 
Grb2 recruits effector proteins to localize together in order to engage in 
downstream signal transduction. More information regarding the cellular actions 
of Grb2 can be found in Chapter 3 discussion (Jang, Zhang et al. 2009, Belov 
and Mohammadi 2012). Grb2 has more recently been found to also be involved 
in cellular transport, utilizing the ability to bind proteins and recruit them to 
membrane systems such as autophagasomes (Roy, Chakrabarti et al. 2014). As 
discussed previously, Grb2 has been implicated in the binding of AICD of APP 
and co-localization in the autophagasome suggesting a possible APP clearance 
mechanism for Grb2 (Roy, Chakrabarti et al. 2014). This finding also is important 
when considering the induced diabetic model, DbAPP, as autophagy 
dysregulation has been evident for some time in metabolic diseases such as 
diabetes mellitus type-2 (Demirtas, Guclu et al. 2016). Whether this upregulation 
is due in part to the AD or metabolic component of this genotype has yet to be 
concluded, though it can be posited that this upregulation of Grb2 may well be an 
attempt to not only put a tighter grip on signaling ability, but also possibly 
increase the cells’ ability to utilize autophagy for either energy efficiency, waste 
control, or both. Grb2, in the current study, was found to be increased in the 
DbAPPi v DbAPPs (2.77-fold, p=0.01). Since Grb2 is in large part responsible for 
the recruitment of effector proteins to TRKs like insulin receptors, it is to be 
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expected that a diabetic model such as the DbAPP model would present with an 
increase in Grb2 levels corresponding to increased signaling activity due to 
downstream insulin signaling. 
 
Superoxide dismutase [Cu/Zn] is located within the cytosol, as opposed to 
manganese SOD within the mitochondria, yet they share the same physiological 
role of scavenging and reducing superoxide to hydrogen peroxide, a less reactive 
form of ROS, though longer lived and still reactive (Abreu and Cabelli 2010). 
However, though the canonical role of SOD may be ROS scavenging, new 
insights into SOD show that it may be a pleiotropic enzyme involved in cell 
survival signaling pathways by way of ERK1/2 and AKT activation, possibly 
through or resulting in intracellular calcium release. SOD was found to be 
significantly decreased in the DbAPPi v Dbi comparison (0.212-fold, p=0.02). 
From this comparison, it appears as if the Alzheimer pathology introduced to the 
diabetic model has a negative effect on SOD levels. Higher SOD levels in 
diabetic models with insulin administration may indicate a pro-survival pathway 
activation, though elucidation as to the pathway activated remains to be clarified. 
 
The mitochondrial permeability transition pore (MPTP) is a structure formed on 
the surface of mitochondria that is vastly associated with cytochrome c release 
and apoptosis (Kinnally, Peixoto et al. 2011). Voltage-dependent anion selective 
channel protein 1 (VDAC1), in the open state, allows for the translocation of ATP, 
ADP and inorganic phosphate and calcium, among other metabolites such as 
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pyruvate in and out of the mitochondria. In the closed state, only calcium is 
allowed to be released into the cytosol and no larger molecules are allowed in, 
which helps regulate calcium signaling and energy production (McCommis and 
Baines 2012). VDAC1, being an important constituent of the MPTP, also helps 
regulate apoptosis when the cell experiences stressors such as high levels of 
oxidative stress. When activated, the MPTP opens releasing pro-apoptotic 
proteins which includes cytochrome-c whereby programmed cell death occurs. A 
recent study utilizing the overexpression of MicroRNA-7 (miR-7), a non-coding 
RNA that has been implicated in a protective role in cellular Parkinson disease 
models, showed inhibition of mitochondrial fragmentation, depolarization, 
oxidative stress generation, and cytochrome-c release in SH-SY5Y cell lines and 
confirmed in mouse primary neurons (Chaudhuri, Choi et al. 2016). Moreover, it 
was shown that miR-7 down-regulated the expression of VDAC1 through 
targeting VDAC1 mRNA. Subsequent down-regulation of VDAC1 resulted in 
decreased cellular oxidative stress and protection against 1-methyl-4-
phenylpyridinium (MPP(+)), a molecule that induces calcium induced cytotoxicity. 
The overregulation of VDAC1 overcame the protective effects of miR-7 against 
MPP(+) (Chaudhuri, Choi et al. 2016). In the present dissertation study, VDAC1 
was found to be significantly reduced in the DbAPPi v DbAPPs comparison 
(0.102-fold, p=0.01). This finding suggests that intra-nasal insulin administration 
may have a protective effect in the highly stressed DbAPP genotype through the 
downregulation of VDAC1. While the activity of miR-7 in the examined mouse 
genotypes are beyond the scope of this dissertation study, it has also been found 
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that miR-7 targets the insulin-like growth factor 1 receptor, inhibiting glucose 
metabolism and cellular growth likely through the regulation of the IGF-1R/AKT 
signaling pathway (Wang, Sun et al. 2014). This connection may indicate that 
IGF-1R/AKT activity and levels may lead to decreased VDAC1 levels through 
insulin receptor cross-talk, inducing a protective state in the highly stressed 
DbAPP model mouse, though the connection between IGF-1R, miR-7, and 
VDAC1 in Alzheimer and diabetic states would need further investigation. 
 
Hypoxathine-guanine phosphoribosyltransferase (HPRT), catalyzes production of 
inosine monophosphate and guanine from hypoxanthine and guanosine 
monophosphate, respectively, thus HPRT is intricately involved in purine 
synthesis by way of the purine salvage pathways (Gherardi and Sarciron 2007). 
Like most salvage pathways, the end result is a recycling of material for 
repurposing which is an important biochemical function that saves the cell energy 
costs associated with the expenditure required for de novo synthesis, but more 
important in tissue types that lack the ability to synthesize the materials at all. In 
the current study, HPRT was found to be significantly increased in the DbAPPi v 
DbAPPs (4.72-fold, p=0.01), DbAPPi v Dbi (5.66-fold, p=0.008), DbAPPi v Dbs 
(3.77-fold, p=0.02), and DbAPPi v Wt (3.60-fold, p=0.03). As of this writing, it is 
not clear the relationship between HPRT and AD or diabetes with insulin 
administration, though it could be presumed that insulin administration and the 
subsequent increase in protein levels observed in this dissertation study reflect 
an attempt by the cell to increase purine turnover much like a proteasome 
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recycles damaged or ubiquitin-tagged proteins. It is possible that this increase in 
purine salvage represents the attempt to mitigate the oxidatively damaged 
nucleotides that have been shown to occur in AD models and brain (Drake, 
Petroze et al. 2004, Lovell, Soman et al. 2011). However, as nucleotide oxidative 
modification was beyond the scope of the proteomics experiments within this 
dissertation study, follow-up studies quantifying nucleotide oxidative 
modifications could help clarify this finding. 
 
4.6 Conclusion: 
In conclusion, this dissertation study, while marred by low sample size and high 
internal standard deviation, did uncover a few interesting findings. It was found 
that protein carbonyls were modestly, but significantly, decreased in the induced-
diabetic/Alzheimer mouse genotype by roughly 10%, and in the APP/PS1 model 
by 9%. What is more, is that expression proteomics uncovered a number of 
proteins experiencing significant changes in expression with the introduction of 
intra-nasal insulin administration as compared to the saline administered mice. 
These proteins span a wide range of cellular systems including the proteasomal 
and apoptotic pathways, energy production, and oxidative stress management. In 
the future, if these findings are to be elaborated upon further, reducing the age at 
which the administration occurs and the duration of the administration would 
likely result in higher animal retention while simultaneously yielding interesting 
results. Moreover, using ANOVA analysis resulted in quite confusing and often 
confounding comparisons which may have been better suited simply comparing 
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the insulin and saline administrations for each genotype separately with a 2-tailed 
Ttest, having the additional effect of retaining more protein comparisons than this 


















CHAPTER 5: COMPARATIVE PROTEOMIC ANALYSES OF THE PARIETAL 
LOBE FROM RHESUS MONKEYS FED A HIGH FAT/SUGAR DIET WITH AND 
WITHOUT RESVERATROL SUPPLEENTATION, RELATIVE TO A HEALTHY 
DIET: INSIGHTS INTO THE ROLES OF UNHEALTHY DIETS AND 


















5.1 OVERVIEW OF STUDY 
A diet consisting of a high intake of saturated fat and refined sugars is 
characteristic of a Western-diet and has been shown to have a substantial 
negative effect on human health. Expression proteomics were used to investigate 
changes to the parietal lobe proteome of rhesus monkeys consuming either a 
high fat and sugar (HFS) diet, a HFS diet supplemented with resveratrol 
(HFS+RSV), or a healthy control diet for 2 years. Here we discuss the 
modifications in the levels of 12 specific proteins involved in various cellular 
systems including metabolism, neurotransmission, structural integrity, and 
general cellular signaling following a nutritional intervention. Our results 
contribute to a better understanding of the mechanisms by which resveratrol 
functions through the up- or down-regulation of proteins in different cellular sub-
systems to affect the overall health of the brain. 
 
5.2 INTRODUCITON 
The Western diet consists of a high amount of saturated fat and refined sugar 
(HFS) content commonly used in food preparation. Long term consumption of 
HFS has been linked to a number of physiological conditions such as obesity, 
insulin resistance and type-2 diabetes mellitus, cardiac disease, ischemia, 
cancer, and cognitive dysfunction (Myles 2014). The projected costs of obesity-
related diseases are measured not only in monetary terms, but also in life-years 
used to treat the disease and life-years lost to early death associated with obesity 
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and unhealthy diets in general. 
 
Resveratrol (RSV) is a polyphenol found primarily in red grapes, blueberries, 
cranberries, nuts such as peanuts and pistachios, as well as in cocoa. RSV has 
garnered widespread acclaim due to the many studies linking it to beneficial 
effects such as neuroprotection, anti-inflammation, regulation of metabolic 
pathways, improved glucose tolerance, and as an antioxidant (Carrizzo, Forte et 
al. 2013, Bastianetto, Menard et al. 2014, Szkudelski and Szkudelska 2014, 
Poulsen, Fjeldborg et al. 2015). The mode of action for RSV appears to be its 
indirect activation of the NAD+-dependent deacetylase, sirtuin-1 (SIRT1), 
possibly through the inhibition of cyclic AMP (cAMP)-degrading 
phosphodiesterase, that leads to the deacetylation of the p65 subunit of NF-κB 
(Howitz, Bitterman et al. 2003, Blander and Guarente 2004, Dai, Kustigian et al. 
2010, Park, Ahmad et al. 2012). 
 
The parietal lobe of the brain is primarily responsible for the integration of 
sensory information, both tactile and perceived, as well as spatial recognition and 
processing of both language and memory. Impairments to the parietal lobe are 
seen in a number of neurodegerative diseases such as Alzheimer disease (AD), 
Parkinson disease, and amyotrophic lateral sclerosis (Cosottini, Pesaresi et al. 
2012, Teixeira, Machado et al. 2014, Brickman, Zahodne et al. 2015).  AD in 
particular, along with its earlier stage, amnestic-mild cognitive impairment 
(aMCI), have been linked to proteome dysfunction in most regions of the brain, 
106 
 
including parietal lobule, indicating that a healthy and functioning proteome is 
necessary for normal brain function (Di Domenico, Owen et al. 2010, Aluise, 
Robinson et al. 2011). Although there has been considerable research on the 
effects of RSV in a number of scenarios and models, a proteomic analysis of the 
primate brain has yet to be conducted. With 95% genetic homology, rhesus 
monkeys are an ideal translational model toward understanding the effects of a 
Westernized diet and the influence of RSV supplementation in a primate brain, 
modeling humans. Through the use of discovery-based proteomics methodology, 
the current study led to the identification of parietal proteins important in energy 
production, cellular signaling, and neurotransmission within the proteome of 
rhesus monkey parietal lobe which might play a role in neurodegenerative 
disease or dysfunction associated with an unhealthy diet. 
 
5.3 MATERIALS AND METHODS 
5.3.1 MATERIALS 
The chemicals used in these experiments were purchased from Sigma-Aldrich 
(St. Louis, MO, USA) with the following exceptions: Criterion precast 
polyacrylamide gels, ReadyStrip™ IPG strips (pH 3-10), Precision Plus Protein™ 
All Blue Standards, Sypro Ruby® Protein Stain, MOPS and TGS running buffers, 
0.2 nm nitrocellulose membrane, mineral oil, dithiothreitol, iodoacetamide, 
biolytes, and urea were purchased from Bio-Rad (Hercules, CA, USA). Modified 
trypsin solution was obtained from Promega (Madison, WI, USA) and C18 ZipTips 
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were acquired from Millipore (Billerica, MA, USA). Anti-alpha-internexin and anti-
chloride intracellular channel protein antibodies were procured from Santa Cruz 
(Dallas, TX, USA). Amersham ECL IgG horseradish peroxidase-linked secondary 
antibodies, ECL-Plus Western blotting chemiluminescent detection reagents as 
well as Re-Blot Plus Strong stripping solutions were purchased from GE 
Healthcare (Pittsburgh, PA, USA). 
5.3.2 Animals 
Twenty-three adult (7-13 years old) male rhesus monkeys (Macaca mulatta) 
were housed at the NIH Animal Center, Poolesville, MD, a center fully accredited 
by the American Association for Accreditation of Laboratory Animal Care. All 
procedures were approved by the Animal Care and Use Committee of the NIA 
Intramural Program. 
5.3.3 EXPERIMENTAL DIET 
Monkeys were randomized into one of three groups: a healthy standard diet 
(Cont, n= 3) or a high fat/high sugar diet in combination with either placebo (HFS, 
n=10) or resveratrol (HFS+RSV, n=10). The Cont diet was a standard purified 
chow consisting of 13% of kcal in fat and less than 5% sucrose by weight (Purina 
Mills, St. Louis, MO). The HFS diet was a specially formulated purified ingredient 
diet with 42% of kcal in fat and approximately 27% sucrose by weight (Harlan, 
Teklad, Indianapolis, IN). The monkeys were gradually switched to the HFS diet 
over a 3-week period. Monkeys received 2 meals per day at estimated ad libitum 
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levels throughout the study and water was always available. The average food 
consumption (kcals/day) for weekly periods was the same for all groups. 
The RSV dose was derived from the protective dose reported in mice (22 mg/kg) 
(Baur, Pearson et al. 2006) and adjusted by allometric scaling to an average 
monkey body weight of 12.1 kg. RSV was supplied by DSM Nutritional Products, 
Parsippany, NJ. HFS+RSV monkeys received 40 mg RSV twice a day for the first 
year which was increased to 240 mg twice a day during the second year in order 
to raise plasma RSV levels. The HFS and Cont monkeys received a placebo 
treat (Bio-Serv, Frenchtown, NJ). Additional experimental details have been 
described previously (Fiori, Shin et al. 2013, Jimenez-Gomez, Mattison et al. 
2013, Mattison, Wang et al. 2014). 
5.3.4 SACRIFICE AND TISSUE HARVEST 
Anesthesia was induced with Ketamine (7-10 mg/kg, IM) and, following blood 
collection, the monkeys were deeply anesthetized with a lethal dose of sodium 
pentobarbital (50 mg/kg, IP). Once maximally sedated, the monkeys were perfused 
with cold lactated Ringer’s solution. Tissues were harvested immediately, flash 
frozen in liquid nitrogen, and stored at -80˚C until use. 
5.3.5 SAMPLE PREPARATION 
The parietal lobules from the brains of rhesus monkeys were thawed at 4°C and 
individual homogenates were prepared with a Wheaton glass homogenizer 
(approximately 40 passes) with ice-cold isolation buffer [0.32M sucrose, 2mM 
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EDTA, 2mM EGTA, 20mM HEPES, 0.2µg/ml PMSF, 4µg/ml leupeptin, 4 µg/ml 
pepstatin, 5 µg/ml aprotinin]. Homogenates were thoroughly vortexed and 
subsequently sonicated on ice for 10 s at 20% power, a total of two times, 
allowing the sample to rest 20 s on ice between vortexings, with a Fisher 550 
Sonic Dismembrator (Pittsburgh, PA, USA). Concentration of the total protein in 
the homogenates was determined by the Pierce BCA method (Rockford, IL, 
USA). 
 
5.3.6 TWO DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS 
(2D-PAGE) 
5.3.6.1 ISOELECTRIC FOCUSING 
Parietal lobe tissue homogenates (200 µg) were shaken in 200 µl of rehydration 
buffer [8 M urea, 2.0% (w/v) CHAPS, 2 M thiourea, 50 mM DTT, 0.2% biolytes, 
0.01% bromophenol blue] for 1.5 hr at RT and then sonicated for 10 s at 20% 
power. Samples were applied to 11 cm pH 3-10 ReadyStrip™ IPG strips with a 
linear gradient. IPG strips were actively rehydrated at 20 °C for 18 h at 50 V 
using a Bio-Rad Protean IEF Cell (Hercules, CA, USA). After the first 60 min, 2 
mL of mineral oil was added to the strips. Next, isoelectric focusing was carried 
out at a constant temperature of 20 °C beginning at 300 V for 2 h, 500 V for 2 h, 
1000 V for 2 h, 8000 V for 8 h, and ending at 8000 V for 10 h. The IPG strips 
were immediately stored at -80 °C until use. 
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5.1.5.2 SDS PAGE. IPG strips were thawed for 10 min and then 4 ml of a DTT-
containing equilibration buffer [50 mM Tris–HCl, pH 6.8, 6 M urea, 1% (w/v) SDS, 
30% v/v glycerol, 0.5% DTT] was added for 10 min in the dark. This solution was 
removed and 4 ml of an iodoacetamide-containing buffer [50 mM Tris–HCl, pH 
6.8, 6 M urea, 1% (w/v) SDS, 30% v/v glycerol, 4.5% iodoacetemide] for 10 min 
in the dark. IPG strips were then rinsed in a 1X dilution of TGS running buffer and 
placed into Criterion precast linear gradient (8–16%) Tris–HCl polyacrylamide 
gels. Precision Plus Protein™ All Blue molecular weight marker was added and 
agarose gel was overlaid. Gels were run at a constant voltage of 200 V for 
approximately 65 min until completion using 1X Tris/Glycine/SDS running buffer. 
5.3.6.2 SYPRO RUBY STAINING 
Following 2D-PAGE, gels were fixed in solution [7% (v/v) acetic acid, 10% (v/v) 
methanol] (50 ml) for 45 min at RT on a gently orbiting platform. Next, the fixing 
solution was removed and 50 ml of Sypro Ruby® Protein Gel Stain was added 
and stained proteins in the gel overnight (15 h) at RT with gentle orbiting. Gels 
were rinsed and transferred to 50 ml of deionized water at RT until scanning.  
Gels were scanned using a Bio-Rad ChemiDocTM XRS+ imaging system 
(Hercules, CA) and stored in deionized water at 4 °C until extraction of protein 
spots. 
5.3.6.3 IMAGE ANALYSIS 
Spot intensities of the imaged SYPRO Ruby®-stained 2D gels were quantified by 
densitometry using PDQuest 2-D Analysis Software (Bio-Rad, Hercules, CA, 
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USA). Individual gel spot intensities were normalized to the total density of the 
respective gel. Spot densities from the three sample groups (Cont, HFS, 
HFS+RSV) were compared and spots with a statistically significant difference 
based on a Student’s two-tailed t-test (p<0.05) were considered for in-gel trypsin 
digestion and the subsequent identification of the protein. 
5.3.6.4 IN-GEL TRYPSIN DIGESTION AND PEPTIDE EXTRACTION 
Statistically significant protein spots were excised from 2D-gels and transferred 
to Eppendorf microcentrifuge tubes. Next, 20 µL of 0.1 M ammonium bicarbonate 
(NH4HCO3) was added to each tube and incubated at RT for 15 min, followed by 
an addition of 30 µL of acetonitrile at RT for 15 min. The solvent was removed 
and gel plugs dried at RT for approximately 30 min. Then, 30 µl of 20 mM DTT in 
0.1 M NH4HCO3 was added to the gel plugs and incubated for 45 min at 56°C. 
After removal of the DTT/NH4HCO3 solution, 30 µl of 0.05 M iodoacetamide (IA) 
in 0.1 M NH4HCO3 was added and gel plugs incubated at RT for 15 min. The IA 
solution was then removed and 150 µl of 0.05 M NH4HCO3 was added to 
incubate for 15 min at RT. Next, 200 µl of acetonitrile (ACN) was added to this 
solution and incubated for an additional 15 min. Gel plugs were dried for 30 min 
at RT before rehydrating with 10 µl of modified trypsin solution in 0.05 M 
NH4HCO3. Plugs were incubated at 37 °C and shaken at 230 RPMs for 15 hrs. 
The digest solution was transferred into a new Eppendorf tube and then 20 µl of 
a 5% ACN, 0.1% formic acid (FA) solution was added to the old tube containing 
the gel plug and sonicated in a bath for 15 min. To this, 30 µl of a 95% ACN, 
112 
 
0.1% FA and 0.001 M NH4CO3 solution was added and sonicated for 15 min. The 
solution was removed from the gel plug tube and combined with the supernatant 
digest solution. Using a Speedy Vac, the samples were subsequently 
concentrated to a volume of approximately 10 µl. Salts and contaminants were 
removed from the trypsin-digested peptide solution with C18 ZipTips. 10 µl of 
100% ACN was aspirated into the tip and expelled a total of 5 times. Next, 10 µl 
of a 50% ACN solution containing 0.1% FA was aspirated and ejected a total of 5 
times. The trypsin digested solution was then slowly drawn up and pushed gently 
out of the column a total of 10 times for peptide adherence. The contaminants 
were eliminated from the peptides in the ZipTip by washing with 10 µl of a 5% 
ACN and 0.1% FA solution a total of 3 times. Peptides were extracted from the 
column with 10 µl of a 50% ACN and 0.1% FA solution by slowly drawing up and 
expelling the eluent a total of 5 times. Samples were stored at -80˚C until MS 
analysis. 
5.3.6.5 NANOLC-MS WITH DATA DEPENDENT SCAN 
The de-salinated samples were reconstituted in 10 µL 5% ACN/0.1% FA and 
analyzed by a nanoAcquity (Waters, Milford, MA)-LTQ Orbitrap XL (Thermo 
Scientific, San Jose, CA) system in data dependent scan mode. An in-house 
packed capillary column (0.1 x 130 mm column packed with 3.6 µm, 200Å XB-
C18) and a gradient with 0.1% FA and ACN/0.1% FA at 200 nL/min were used 
for separation. The MS spectra were acquired by the orbitrap at 30,000 
resolution and MS/MS spectra of the six most intense ions in MS scan were 
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obtained by the orbitrap at 7,500 resolution. Data files from each sample were 
searched against the most current version of the Swiss-Prot database by 
SEQUEST (Proteome Discoverer v1.4, Thermo Scientific). A minimum of two 
high-confidence peptide matches were required for protein identification (false 
discovery rate <1%). Proteins matched with the same peptides are reported as 
one protein group. Resultant MS/MS data were initially verified by comparison of 
the expected molecular weight and isoelectric point of the identified protein to 
that of the extracted plug from the 2-D gel. 
5.3.7 ONE DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS (1D-
PAGE) 
Parietal lobule homogenates (50 µg) were suspended in 4X sample loading 
buffer [0.5 M Tris, pH 6.8, 40% glycerol, 8% SDS, 20% β-mercaptoethanol, 
0.01% Bromophenol Blue] diluted to 1X with distilled water. Samples were then 
heated at 95 °C for 5 min, cooled on ice and loaded into a CriterionTM precast (4-
12%) Bis-Tris polyacrylamide 12 well gel with Precision Plus Protein™ All Blue 
Standards.  Gels were run at RT in a Criterion Cell™ vertical electrophoresis 
buffer tank (Bio-Rad, Hercules, CA, USA) containing a 1X dilution of XT MOPS 
running buffer at 80 V for 15 min. Voltage was then increased to 120 V for the 
duration of the electrophoretic run (approximately 100 min). 
5.3.7.1 1D-WESTERN BLOTTING  
Proteins in the gel were transferred to a nitrocellulose membrane (0.2 nm) using 
a Trans-Blot TurboTM Blotting System (Bio-Rad, Hercules, CA, USA). After the 
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transfer, membranes were placed in a blocking solution of 3% bovine serum 
albumin (BSA) in Wash Blot [150 mM NaCl, 3 mM NaH2PO4, 17 mM NaHPO4 
and 0.04% (v/v) Tween 20] at RT for 1.5 h. Alpha-internexin and anti-chloride 
intracellular channel proteins were detected with polyclonal primary antibodies 
raised in rabbits (1:8000 dilution in blocking solution.) Blots were incubated at RT 
with gentle rocking for 2 h. Next, the membranes were rinsed three times in 
Wash Blot (5 min, 5 min, 10 min), followed by a 1 h incubation with a rabbit 
horseradish peroxidase (1:3000) secondary antibody at RT with gentle rocking. 
Blots were rinsed three times (5, 10 and 10 min) in Wash Blot and developed 
chemiluminescently using ClarityTM Western ECL Substrate. After developing for 
5 min at RT in the dark, blots were scanned using a Bio-Rad ChemiDocTM XRS+ 
imaging system and quantified using Image LabTM software (Bio-Rad, Hercules, 
CA, USA). The membranes were then rinsed with Wash Blot for 5 min, two times, 
and then stripped with Re-Blot Plus Strong solution for exactly 10 min at RT, 
followed by three 5 min rinses with Wash Blot. The membranes were then 
blocked once again in 3% BSA for 1.5 h. Next, anti-tubulin antibodies raised in 
mice (1:20000) were added to the Wash Blot solution for 2 h of gentle rocking at 
RT. Membranes were then washed, incubated with a secondary HRP-conjugated 







5.3.8 STATISTICAL ANALYSIS 
An ANOVA was performed followed by a Bonferroni correction for multiple 
comparisons in order to determine the effects of HFS and HFS+RSV diets on the 
expression of proteins within the tissue of the parietal lobule. An α<0.05 was 
selected as a measure of significance for the ANOVA while a p<0.05 was 
selected as a measure of significance for the multiple comparisons test. Fold-
change values of differentially expressed proteins were determined by dividing 
the average spot intensity of the gels from the HFS or HFS+RSV diet groups by 
the average spot intensity of the gels of the Cont diet group. For the fold-change 
comparisons between the HFS and the HFS+R, the average spot intensities of 
the gels from the HFS+RSV were divided by those of the gels from the HFS diet. 
Proteins that were identified by the SEQUEST search algorithm with p<0.01 were 
considered to be statistically significant. To further validate MS/MS identification 
of significant differentially expressed proteins, the position of protein spots on the 
2D-gel images were manually examined to confirm that they were located near 









5.4.1 EXPRESSION PROTEOMICS ANALYSIS 
Proteomic identifications of proteins from rhesus monkey parietal lobules 
following two years of a diet intervention were conducted using a 2D-PAGE 
approach with Sypro Ruby staining. Protein spot intensities were compared 
between these three groups to determine differentially expressed proteins. Figure 
5.4.1a shows representative examples of 2-D gel images of the isolated proteins 
for the Cont and HFS comparison with the five differentially expressed proteins 
identified and listed in Table 5.4.1a. Gel images for the Cont and HFS+RSV 
comparison are shown in Figure 5.4.1b. Five proteins were identified and listed in 
Table 5.4.1b. Figure 5.4.1c illustrates the four differentially expressed proteins 
between HFS and HFS+RSV diet groups which are listed in Table 5.4.1c. 
PDQuest analysis of 2-D images for all three groups identified protein spots 
suitable for extraction and whose expression was significantly altered in the 
parietal lobules, and five of the proteins were significant in multiple comparisons. 
Protein spot extraction was followed by in-gel trypsin digestion, peptide 
extraction, removal of metal ions with buffers, and MS/MS analysis coupled to 






Table 5.4.1a: Proteins with altered expression in parietal lobe of Rhesus 
monkeys in the Control vs HFS comparison 
 
 
Figure 5.4.1a: Representative excision gels Rhesus Monkey (Cont vs HFS) 
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Table 5.4.1b: Proteins with altered expression in parietal lobe of Rhesus 
monkeys in the Control vs HFS+R comparison 
 
 




Table 5.4.1c: Proteins with altered expression in parietal lobe of Rhesus 
monkeys in the HFS vs HFS+R comparison 
 
 





Fold-change values were calculated by dividing the average spot intensity of the 
gel protein spots of the HFS or HSF+RSV diet group by the average spot 
intensity of the Cont diet gel spots, or by dividing the average spot intensity of the 
gel protein spots of the HFS+RSV by the average spot intensity of the gel protein 
spots of the HFS diet. To expound, a fold increase of 1.75 in the HFS+RSV 
group represents a 75% increase in protein level of the HFS+RSV group 
compared to the group used as a Cont in the comparison. Moreover, a fold value 
less than 1, denotes a decrease in protein level; for example, a fold-change of 
0.25 represents a decreased protein level of 75%.  
5.4.2 WESTERN-BLOT VALIDATION EXPERIMENTS 
Western blot experiments were conducted on a selected protein to validate the 
changes in protein levels as determined by the PDQuest analysis of the 2-D gels. 
Figure 4 is a Western blot image of the three groups after probing with chloride 
intracellular channel protein and tubulin antibodies. Analysis of this blot showed a 
65.6% decrease in levels of chloride intracellular channel protein in the HFS 
group compared to Cont (p=0.008), as well as a 72.3% decrease in HFS+RSV 
compared to Cont ( p=0.0051). PDQuest data from the protein spot identified as 
chloride intracellular channel protein by MS/MS analysis showed a 98.7% 
decrease in levels from the Cont diet to the HFS diet (p=0.0234), and a 62.77% 
decrease in levels from the Cont diet to the HFS+RSV diet (p=0.0294). Figure 5 
is the Western blot image of the samples after probing with a primary alpha-
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internexin antibody, whereas tubulin was the loading control. The HFS group 
demonstrated only a trend (p=0.059) toward a decreasae compared to Cont 
despite a 32.8% reduced levels of alpha-internexin.  HFS+RSV had a 41.7% 
increase in levels of alpha-internexin compared to the HFS group (p=0.0159) but 
was not different from Cont.The variations in fold changes between the two 
detection methods may be attributed to the sensitivity of the Sypro Ruby staining 
method of the 2-D gels contrasted to the range limitations involved with the 
chemiluminescent development of the 1-D Western blot. These validation 
experiments support the findings in the proteomics identification of the main 





















Figure 5.4.2b: AIN Western blot validation 
 
 
5.5 DISCUSSION OF RESULTS 
Discovery-based expression proteomics was used to compare the effects of 
three experimentally controlled dietary conditions in adult male rhesus monkeys: 
a standard healthy control diet, a Westernized diet high in fat and sugar, and the 
HFS diet supplemented with RSV. Ten proteins were identified in the HFS 
124 
 
groups with a significant differential expression when compared to Cont diet 
monkeys. The functions of these proteins vary greatly but all can be considered 
contributing to the proper functioning of biological systems such as metabolism, 
structural integrity, neurotransmission, and cellular signaling. RSV’s greatest 
effects reportedly occur within a metabolically impaired state such as obesity and 
diabetes, while healthy individuals benefit less (Ghanim, Sia et al. 2010, 
Timmers, Konings et al. 2011, Crandall, Oram et al. 2012, Marchal, Blanc et al. 
2012, Yoshino, Conte et al. 2012). A recent study published by collaborators 
using the monkeys from which our samples were derived measured the levels of 
RSV in the CSF of HFS+R, but were unable to detect RSV in the Cont and HFS 
groups demonstrating the efficacy of the RSV supplementation (Bernier, Wahl et 
al. 2016). Moreover, they were able to measure SIRT1 and SIRT2 levels and 
activity (via acetylated tubulin). While it was found that SIRT1 levels were 
unchanged across the three groups, the HFS+R group had a significant reduction 
in SIRT2 levels that accompanied an increase in expression of α-tubulin and a 
reduction in the ratio of acetylated tubulin/total tubulin, of which the authors 
suggest may be due to compensatory mechanisms of acetylation (Bernier, Wahl 
et al. 2016).  
 
Here, we identified a number of parietal lobe proteins of differential levels in 
monkeys consuming an HFS diet for two years. In several, but not all cases RSV 
supplementation was associated with a change in the expression profile 
suggestive of improved function. Those proteins exhibiting level changes 
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associated with treatment are classified here by cellular sub-systems and 
discussed in that context. A graphical illustration of the protein and a primary 
canonical function is provided in Figure 6. 
 
Figure 5.5: Identified proteins and representative cellular responsibilities 
(Permission Granted by Elsevier)  
 
5.5.1.1 ENERGY 
The production and maintenance of cellular stores of energy is a complex and 
necessary function of all systems within an organism, however, the brain is 
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unique in its energy consumption needs. The brain is a small fraction of the total 
mass of an organism, yet it consumes upwards of 30% of all inspired oxygen and 
20% of ingested glucose for its energy needs. This energy is used to maintain 
neuronal cell resting potentials, neurotransmitter production and release, as well 
as the propagation of action potentials, among other functions. Moreover, the 
brain is highly dependent upon glucose for its functioning, and any severe 
decrease in glucose metabolism may prove to be detrimental to the health of the 
organism. Therefore, an analysis of proteomic changes to the levels of metabolic 
enzymes as a function of diet could prove useful in understanding the effects of a 
Western diet and/or resveratrol supplementation on the brain. 
Pyruvate kinase was significantly decreased (0.11-fold) in the HFS group 
compared to Cont. As glucose is the primary source of energy for the brain, we 
posit that the observed decrease in these two glycolytic enzymes following two 
years on HFS diet represent energy impairment imparted by the unhealthy diet. 
Resveratrol supplementation to an HFS diet appeared to preferentially act on 
ENO1 levels as alpha-enolase (ENO1) was 3.15-fold higher in the HFS+RSV 
compared to HFS group. ENO1, is most commonly known for its role in glycolysis 
in which it catalyzes the production of phosphoenolpyruvate from 2-
phosphoglycerate. A loss of glycolytic enzymes could potentially have a negative 
effect on the efficiency of glucose utilization and thus, normal brain function. 
However, ENO1 is a pleiotropic enzyme with many functions beyond glucose 
metabolism. ENO1 has been shown to exhibit functions of a heat shock protein, 
a hypoxic-stress protein, a neurotrophic factor, as well as a transcription 
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modulator (Butterfield and Lange 2009). Enolase has been found to be 
compromised in several neurodegenerative diseases such as AD, Huntington’s 
disease, and amyotrophic lateral sclerosis (Castegna, Aksenov et al. 2002, 
Perluigi, Fai Poon et al. 2005, Perluigi, Poon et al. 2005). 
BACH protein was 58.2-fold lower in the HFS monkey parietal lobe compared to 
Cont. BACH cleaves acyl-CoA into coenzyme-A (CoASH) and the resultant fatty 
acid. Fatty acids, acyl-CoA, and CoA-SH all serve diverse biological functions 
important in processes such as ß-oxidation and metabolism in general, lipid 
synthesis, gene regulation, cellular signaling, and enzymatic regulation. 
Additionally, within the brain, they serve as an energy source, and in the process 
of lipid synthesis and homeostasis, cellular signaling, enzyme regulation, vesicle 
trafficking, and gene expression, bio-molecular trafficking, and ion flux (Hunt and 
Alexson 2002, Yamada, Kuramochi et al. 2002, Yamada 2005, Hulbert, 
Pamplona et al. 2007). BACH has been found to be crucial in preventing 
neurotoxicity via dysregulation of fatty acid metabolism while also regulating cell 
and membrane stability, potentially impacting the aging rate (Hulbert, Pamplona 
et al. 2007, Ellis, Wong et al. 2013). BACH is more active in the brain than in any 
other organ system and our data suggest that long-term consumption of an HFS 
diet by a nonhuman primate may impair its expression levels. This finding may 
have direct implications on healthy brain function as previous research has 






Microtubules are structural protein complexes that provide structural integrity to 
the cell, as well as roles in cellular processes such as cell division, ciliary/flagellar 
movement, and intracellular transport. Microtubules are composed of alpha- and 
beta-tubulin that self-assemble into large polymers. However, due to rapidly 
changing complex needs of the cell, microtubules must be dynamic in their 
construction and deconstruction. Stathmin is a key protein in the regulation of 
microtubule assembly and disassembly and impedes formation of microtubules 
through the sequestration of soluble tubulin into T2S complexes (Curmi, Gavet et 
al. 1999). Therefore, the levels of stathmin may directly affect microtubule 
turnover and dynamics. Moreover, an overexpression of stathmin is found to be 
present in various forms of cancers and in AD progression, while also being 
positively correlated to telomere shortening (Belletti and Baldassarre 2011, Ahn, 
Yoo et al. 2014). In the current study, monkeys fed HFS+RSV have a 0.69-fold 
decrease of stathmin compared to HFS fed monkeys. This decrease in stathmin 
may allow for increased microtubule formation and stability, consistent with more 
efficient intracellular transport of vesicles and mitochondria. 
Collapsin response mediator protein-2 (CRMP-2; also called 
dihydropyrimidinase-related protein 2 (DRP-2)) is important in the proper 
functioning of neurons, and its aberrant expression and/or inactivity has been 
implicated in neurodegenerative diseases such as AD (Butterfield, Perluigi et al. 
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2006, Hensley, Venkova et al. 2011). The primary roles of CRMP-2 are control of 
the dynamic stability of microtubules, neural differentiation and specification for 
axons and dendrites, the proper outgrowth/retraction of neurites, 
neurotransmitter release, indirect control of axonal transport, and calcium 
homeostasis (Goshima, Nakamura et al. 1995, Inagaki, Chihara et al. 2001, 
Yoshimura, Kawano et al. 2005, Hensley, Christov et al. 2010, Hensley, Venkova 
et al. 2011). CRMP-2 is the only CRMP to be maintained at high levels in adult 
neurons and is mostly expressed in areas requiring high degrees of plasticity 
such as the hippocampus, cerebellum, and olfactory bulb (Charrier, Reibel et al. 
2003). Within the neuron, CRMP-2 is found within the growth cone and 
synapses, indicative of its function (Chu, Wang et al. 2010). Here, we showed 
that levels of CRMP-2 are significantly reduced in HFS and HFS+RSV compared 
to Cont at 0.079-fold and 0.011-fold, respectively. These data indicate that 
CRMP-2 may be decreased in response to a HFS, unhealthy diet and RSV was 
not protective in monkeys. The implementations of this reduced level is that 
neuritic extensions would be shorter, thereby making fewer synaptic connections. 
HFS could therefore lead to detrimental cognitive changes. 
Oligodendrocytes are one of the major cell types of the CNS as a component of 
the myelin sheath, wrapping around the adjacent neuronal axons to allow 
saltatory impulse propagation. Oligodendrocytes are associated with 2,3-cyclic 
nucleotide 3-phosphodiesterase (CNP), which plays an important, albeit not well 
understood, role in myelin formation. CNP is located in non-compacted myelin 
regions while absent in compacted sheath (Braun, Sandillon et al. 1988, Trapp, 
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Bernier et al. 1988). Lappe-Seifke et al. silenced the Cnp1gene in mice, which 
resulted in fully myelinated offspring, but with severe axonal swelling and death 
by 12 months (Lappe-Siefke, Goebbels et al. 2003). In Cnp-1 null mice, the 
absence of CNP led to disorganized oligodendroglial paranodes and altered 
communication between neuronal axons and oligodendrocytes and 
consequential neurodegeneration (Rasband, Tayler et al. 2005). In our 
HFS+RSV fed nonhuman primates, CNP was down regulated 0.492-fold 
compared to the HFS-fed group indicating that RSV supplementation appears to 
have a detrimental impact on CNP performance. 
 
Vacuolar H+-ATPases (V-Type ATPase) have a structure and mechanistic action 
similar to that of F-Type ATPases, which are found in the inner mitochondrial 
membrane and used for oxidative phosphorylation, yet the ultimate function they 
perform differs. While F-Type ATPases use proton gradients to drive ATP 
production, V-Type ATPases use ATP to drive proton gradients (Nishi and 
Forgac 2002). The establishment of an electrochemical proton gradient across a 
lipid bilayer is used in a variety of processes from the acidification of lysosomal 
luminal space, to the packaging of neurotransmitters into synaptic vesicles and 
endocytic transportation (Maxson and Grinstein 2014). For instance, the 
environment of an endocytic vesicular lumen made acidic in comparison to the 
surrounding cytosol by V-Type ATPases allows for the dissociation of ligands 
and receptors for recycling of the components (Maxfield and McGraw 2004). In 
regards to protein degradation and turnover, V-Type ATPases play an important 
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role in the autophagic pathway in direct and possibly indirect manners. First, V-
Type ATPases directly acidify the lysosomal luminal space to a pH of around 4.5 
in order to provide an optimal environment for lysosomal protease functioning 
(Huynh and Grinstein 2007, Maxson and Grinstein 2014). A less well 
characterized function of V-Type ATPases in regards to induction of autophagy is 
their proposed ability to activate lysosomal bound mTORC1, a required step for 
mTORC1 activation. It is hypothesized that due to V-Type ATPases interaction 
with both mTORC1 and Ragulator, that V-Type ATPases may sense levels of 
available amino acids and convey that information to mTORC1 (Zoncu, Bar-
Peled et al. 2011, Bar-Peled, Schweitzer et al. 2012, Xu, Parmar et al. 2012). In 
this study, we found a significant increase in isoform 3 of V-Type proton ATPase 
subunit E-1 protein level (4.67-fold) in the HFS+RSV group compared to Cont. 
We hypothesize that an increase in V-Type ATPase levels with RSV 
supplementation represents the cellular attempt at an autophagy response as 
needed while preserving the necessary brain functions such as neurotransmitter 
processing and lysosomal efficacy. 
 
5.5.1.3 SIGNALING 
One method of signal transduction is through the activation of transmembrane G-
protein coupled receptors (GPCRs). GPCRs participate in many signaling and 
physiological functions such as neurotransmission, peptide hormone signaling, 
vision, taste, and smell (Rosenbaum, Rasmussen et al. 2009). GPCRs have a 
small G-protein docked to the intracellular side of the receptor, which upon 
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receptor activation is itself activated by the replacement of GDP with GTP in its 
regulatory site causing the G-protein to split into Gα and Gβγ subunits. Upon 
activation of the Gα-subunit by GTP, the Gα-subunit is free to activate 
downstream effectors such as adenylate cyclase (AC), a signal amplifying 
enzyme that creates the secondary messenger cyclic-AMP (cAMP) from ATP. 
Following this process, the Gα-subunit’s GTPase activity slowly turns the GTP 
back to GDP, deactivating itself to start the cycle anew. Guanine nucleotide-
binding protein (Gi/Gs/Gt)-1 (GNB1), the β subunit, is responsible for the GTPase 
activity, which allows for the activation of the G-protein, guanine nucleotide 
exchange, and also for downstream signaling of the Gβγ complex (Oldham and 
Hamm 2008). In the present study, the HFS+RSV diet led to an increase in 
GNB1 by 3.61-fold over that of the brain of monkeys fed the HFS diet alone, 
whereas GNB1 was found to have a significant decrease in levels (0.27-fold) in 
the HFS compared to Cont. The results suggest that while the HFS diet alone 
may have a detrimental role in levels of GNB1, RSV may attenuate that loss, 
suggestive of a protective effect. GNB1 is necessary for the direct activation of 
downstream effects such as phosphoinositide-3-kinase, phospholipase-C 
isoforms, and ion channels, while indirectly participating in all Gα activities due to 
their regulatory nature over the Gα subunit (Cabrera-Vera, Vanhauwe et al. 
2003). Here, our proteomics studies are consistent with the notion that addition of 
RSV to a HFS diet promotes cellular signaling in brain that is diminished in brain 




Glutamine synthetase is a key protein of astrocytes in the brain as it is involved in 
the glutamate-shuttle and subsequent conversion of the neurotransmitter 
glutamate to inactive glutamine prior to being translocated back to the neuron. 
The glutamate shuttle is important for the health of the neuron as glutamate is an 
excitatory neurotransmitter which if left in the synapse and not converted to 
glutamine may cause excitotoxicity and subsequently neuron death through 
calcium dysregulation (Takahashi, Foster et al. 2015). However, the glutamine 
shuttle is not solely responsible for glutamate availability at the synapse (Danbolt 
2001). We report that glutamine synthetase has significantly reduced levels 
(0.76-fold) in the HFS+RSV when compared to Cont, and decreased but not 
significantly decreased levels in HFS compared to Cont suggesting that the HFS 
diet depressed levels of glutamine synthetase that are not recovered, and 
perhaps even exacerbated, with RSV supplementation. It has been suggested in 
a 3x-TG-AD mouse model that depression of glutamine synthetase levels may 
lead to errant glutamate homeostasis and regulation as well as memory and 
cognitive impairment that may be attributed to failures in synaptic connectivity, all 
of which are apparent in human AD (Kulijewicz-Nawrot, Sykova et al. 2013). 
 
Chloride intracellular channel protein 4 (CLC-4) is a multifunctional protein 
predominantly known for its role as a chloride channel, as its name implies. 
However, CLCs have recently been shown to participate in other physiological 
roles such as a mediator of apoptosis in which this protein is translocated to the 
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nucleus (Ryu, Peixoto et al. 2010, Qian, Du et al. 2011). The suppression of 
CLC-4 with siRNA is reported to be involved in enhanced hydrogen peroxide 
mediated apoptotic activation (Xu, Kang et al. 2013), whereas others showed 
siRNA interference of CLC-4 enhanced TNFα-mediated apoptosis in a p53-
independent manner (Suh, Mutoh et al. 2005). However, the role of CLC-4 in 
apoptosis is complex, as demonstrated by its ability to be highly apoptotic in and 
of itself when Apaf1 is deleted, inhibiting the mitochondrial apoptotic pathway 
(Suh, Mutoh et al. 2004). Here, we show a significant decrease in CLC-4 in both 
the HFS vs Cont and HFS+RSV vs Cont groups with 0.28-fold and 0.37-fold 
protein level of control, respectively. We posit that this decrease in CLC-4 levels 
in both unhealthy diet groups is indicative of potential apoptotic regulation, and 
as oxidative stress is a hallmark of both diabetes and AD, it is possible that 
hydrogen peroxide mediated apoptosis is in part responsible for cognitive 
deficiencies, though follow-up research is needed to clarify this speculation. 
 
SH3 domain-binding glutamic acid-rich-like protein (SH3BGRL) is homologous to 
glutaredoxin 1 in E. coli, an oxioreductase, thought to belong to the thioredoxin-
like protein family (Egeo, Mazzocco et al. 1998). SH3BGRL2, a homologue of the 
SH3BGRL family, was later identified and shown to have a high similarity to other 
SH3BGRL homologue N-terminal region (Mazzocco, Maffei et al. 2002). While 
SH3BGRL proteins may belong to the thioredoxin-like super family of proteins, all 
homologues are devoid of the CXXC motif indicating that they most likely do not 
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have any thioredoxin-like enzymatic activity (Mazzocco, Maffei et al. 2002). 
However, due to its shared homology, specifically to that of glutaredoxin, it is 
possible that SH3BGRL proteins participate in the regulation of redox sensitive 
proteins, possibly through the action of its PICOT homology domain, allowing it to 
engage in protein-protein interactions hinting at its role as a protein regulator 
(Mazzocco, Maffei et al. 2002). Research supports the notion of SH3BGRL 
protein SH3BGRL3 as acting as an indirect inhibitor of TNF-α through the 
activation of NF-κB by way of its PICOT homology (Witte, Villalba et al. 2000, Xu, 
Zheng et al. 2005). Here we observed a decreased level of SH3BGRL2 (0.69-
fold) in HFS+RSV diet fed monkeys vs Cont monkeys. As both SH3GBRL2/3 
share similar PICOT homology, it is possible that RSV supplementation in an 
HFS diet modulates the inflammatory response through SH3BGRL2/3 decrease 
of active TNF-α and subsequently modulating the inflammatory response, though 
this speculation needs further study to confirm. 
5.6 CONCLUSION: 
Using proteomics, we have identified a number of proteins with differential 
expression in the parietal lobule of adult male rhesus monkeys fed Cont, HFS or 
HFS+RSV diets over a duration of two years. Our findings suggest potential 
improvements in energy metabolism, efficiency of canonical cell signaling 
pathways, and neurotransmission with RSV supplementation to an HFS diet. In 
contrast, some brain protein levels such as CNP and glutamine synthetase may 
not be attenuated by RSV supplementation of an unhealthy diet. While it has 
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been shown in other studies that resveratrol addition to a normal diet may not 
provide significant benefits to healthy individuals, it has been observed that 
resveratrol does lead to marked improvement in individuals already exhibiting 
signs of metabolic syndrome (Timmers, Konings et al. 2011, Crandall, Oram et 
al. 2012, Yoshino, Conte et al. 2012). Our studies contribute to the understanding 
of the changes occurring in the proteome of the dietary-impaired parietal lobule 















CHAPTER 6: CONCLUSIONS AND FUTURE STUDIES 
The Pin1 overexpression study yielded a number of interesting proteins with 
differential expressions from a wide range of cellular processes including 
structure (Neurofilament-light and Actin Related Protein 3), signaling 
(Phosphatidylethanolamine-binding protein 1, Myc box-dependent-interacting 
protein 1, Growth factor receptor-bound protein 2 and Cofilin-1), immune 
response (Immunity related GTPase family Q protein and Dopachrome 
decarboxylase) and finally energy production and utilization (Glyceraldehyde-3-
phosphate dehydrogenase and Carbonic Anhydrase). While Pin1 overexpression 
may be well intended, there are possibilities that it could be a detriment to the 
organism as a whole due to Pin1 being highly involved in many signaling 
processes, such as cell signaling and the possibility that overexpression could 
lead to cancer and has been noted previously (Xu and Etzkorn 2009). While the 
use of Pin1 overexpression in humans likely not to be used due to possible 
ethical concerns, any study using differential levels of such ubiquitous signaling 
proteins should use caution. Therefore, if this study were to be elaborated upon 
and extended, the effects upon oncogenesis should be taken into account. This 
is especially important and relatable due to the fact that the link between AD and 
the cell cycle possibly initiating in post-mitotic neurons has not been fully 
established (van Leeuwen and Hoozemans 2015). 
 
In regards to the intra-nasal insulin administration study, while not much oxidative 
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stress information was able to be garnered from the animals used, a small but 
significant decrease in protein carbonyls in APP/PS1 and dbdbxAPP/PS1 mouse 
models was found. Also using expression proteomics, a number of proteins from 
different cellular processes were found to be differentially expressed in a number 
of comparisons as a function of treatment including energy and metabolism (ATP 
synthase subunit d, mitochondrial), structure (Stathmin), molecular recycling and 
management (Proteasome subunit alpha type-5, Transitional endoplasmic 
reticulum ATPase, and Hypoxathine-guanine phosphoribosyltransferase), 
signaling (Growth factor receptor-bound protein 2 and Voltage-dependent anion 
selective channel protein 1) and oxidative stress management (Superoxide 
dismutase 1). 
 
This study shows promise, however, fell victim to low sample sizes due to the 
fact that too many animals died during the course of the treatment. Our study 
took place over the course of two months, from 8 months to 10 months of age. 
These mice, particularly the dbdbxAPP/PS1 mice, have drastically shortened 
lifespans and many health complications. It would have been beneficial to 
shorten the length of treatment and begin treatment at an early time frame in 
order to preserve the sample size needed for such an adventurous study while 
also yielding interesting results in regards to the action of insulin on the disease 
states utilized. If given more funding and time, I would do just this and use the 
additional sample size to verify the oxidative stress measures within this 
dissertation that were called into question due to sample standard deviation.  
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Moreover, delving into the actual signaling components behind the scenes of 
protein level changes would yield quite a bit of interesting information and 
possibly new leads as to the method of action of intra-nasal insulin in the 
prevention of cognitive dysfunction. For example, due to IRS1 interaction with 
BVR-A, and the pleiotropic nature of BVR-A in signaling and oxidative stress 
prevention through bilirubin production, BVR-A activity and levels in each group 
as a function of insulin administration. 
 
The resveratrol study also yielded proteins from a wide range of cellular 
processes including energy and metabolism (Pyruvate Kinase, Enolase, and 
BACH), structure (Stathmin, Collapsin response mediator protein-2, 2,3-cyclic 
nucleotide 3-phosphodiesterase, and Vacuolar H+-ATPase) and signaling 
(Enolase, Guanine nucleotide binding protein-1, Glutamine Synthetase, Chloride 
Intracellular channel protein-4, and SH3 domain-binding glutamic acid-rich-like 
protein). These proteins and their differential expression in regards to diet and 
supplementation yielded information towards to effects of resveratrol on protein 
expression in a Western-diet as well as that of a Western-diet over a normal diet. 
Because of the nature of the study and the cost of raising non-human primates, 
the samples given were extremely small and therefore we had to make the 
decision of whether to proceed with oxidative stress measures or expression 
proteomics and decided that expression proteomics would yield the most data at 
the cost of sample. Therefore, the next step should more sample be provided 
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would be to use that sample for oxidative stress measure on the parietal lobe of 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































Pin1/Tubulin  Avgavg  %Control  Avg  Stdev  SEM  
GFP  10.727     154.8301          
GFP  5.716808     82.51461          
GFP  4.666989     67.36185          
GFP  5.692567     82.16471          
GFP  6.086991     87.85771          
GFP  8.679073     125.271          
                    
                    
                    
      6.928238     100  33.11038  14.80741 
                    
Pin1  31.81288     459.1771          
Pin1  13.93558     201.1418          
Pin1  10.88674     157.1358          
Pin1  36.72627     530.0954          
Pin1  26.79006     386.6793          
Pin1  35.92827     518.5772          
Pin1  26.34543     380.2617          
Pin1  39.99102     577.2178          
Pin1  0.046643     0.673236   Qtest       
            401.2858  153.5182  68.65543 
         t‐test  0.000532       
 












Pin1/Tubulin  Avgavg  %Control  Avg  Stdev  SEM  
GFP  5.830565     87.8494          
GFP  6.606754     99.54428          
GFP  6.483299     97.68417          
GFP  6.589165     99.27926          
GFP  5.488294     82.69239          
GFP  6.46932     97.47356          
GFP  7.463709     112.4561          
GFP  8.164897     123.0209          
                    
      6.637001     100  12.78827  5.719086 
                    
Pin1  12.75024     192.1085          
Pin1  18.51177     278.9177          
Pin1  19.97717     300.997          
Pin1  13.27667     200.0402          
Pin1  29.31275     441.6565          
Pin1  16.18672     243.886          
Pin1  18.49807     278.7113          
Pin1  23.49671     354.026          
                    
            286.2929  82.08208  36.70822 
         t‐test  1.82E‐05       
 















Pin/Tubulin  Avgavg  %Control  Avg  Stdev  SEM  
GFP  3.237865     74.30192          
GFP  3.895522     89.39373          
GFP  3.24245     74.40714          
GFP  3.258242     74.76954          
GFP  3.643145     83.60221          
GFP  5.314786     121.9627          
GFP  3.500161     80.32104          
GFP  4.380138     100.5146          
GFP  8.74711     200.7271          
      4.357713     100  40.84907  18.26826 
                    
Pin1  14.21971     326.3112          
Pin1  16.88588     387.494          
Pin1  16.77877     385.0362          
Pin1  14.60185     335.0805          
                    
                    
                    
                    
            358.4805  32.29763  14.44394 
         t‐test  2.55E‐07       
 















Pin1/Tubulin  Avgavg  %Control  Avg  Stdev  SEM  
GFP  2.054185     133.6256          
GFP  1.722488     112.0486          
GFP  1.282583     83.43263          
GFP  2.008937     130.6822          
GFP  1.3437     87.40831          
GFP  0.709421     46.14816          
GFP  1.434925     93.34249          
GFP  1.741909     113.3119          
      1.537268     100  28.71493  12.84171 
                    
Pin1  18.34401     1193.286          
Pin1  5.636706     366.6703          
Pin1  10.73396     698.249          
Pin1  8.448186     549.5583          
Pin1  13.32361     866.7071          
                    
                    
                    
            734.8941  315.7447  141.2053 
         t‐test  0.000118       
 












   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  3464714     84.89407          
Saline  3213446     78.73737          
Saline  4409173     108.0356          
Saline  2589575     63.45098          
Saline  4353913     106.6816          
Saline  6456504     158.2003          
                    
                    
      4081221     100  33.20425  14.84939 
                    
Insulin  3310523     81.116          
Insulin  2812570     68.91491          
Insulin  6236496     152.8096          
Insulin  6160327     150.9433          
                    
                    
            113.4459  44.66087  19.97295 
            0.597669       
      4629979             
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  6900897     99.46383          
Saline  5561228     80.15494          
Saline  6665079     96.06493          
Saline  3606854     51.98621          
Saline  8534786     123.0134          
Saline  10359740     149.3167          
                    
                    
      6938097     100  33.69474  15.06875 
                    
Insulin  7763934     111.9029          
Insulin  7274736     104.852          
Insulin  9799472     141.2415          
Insulin  7413528     106.8525          
                    
                    
            116.2122  16.94789  7.579327 
            0.405267       
      8062917             
 














   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  17719200     102.8958          
Saline  16512450     95.88816          
Saline  17866350     103.7503          
Saline  17270900     100.2925          
Saline  16733750     97.17326          
Saline  9389800     54.52678  Qtest       
                    
                    
      17220530     100  3.443599  1.540024 
                    
Insulin  15983050     92.81393          
Insulin  15516050     90.10205          
Insulin  15386850     89.35178          
Insulin  15692900     91.12902          
                    
                    
            90.84919  1.498772  0.670271 
            0.001746       
      15644713             
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  16112372     94.26506          
Saline  17415012     101.8861          
Saline  18480890     108.122          
Saline  16752786     98.01179          
Saline  16702059     97.71501          
Saline  8960142     52.4211  Qtest       
                    
                    
      17092624     100  5.28177  2.362079 
                    
Insulin  11722655     68.58312          
Insulin  15474566     90.53359          
Insulin  16094834     94.16245          
Insulin  16142120     94.4391          
                    
                    
            86.92956  12.35973  5.527439 
            0.067663       
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  2978910     78.81728          
Saline  4591944     121.4956          
Saline  3402972     90.03729          
Saline  3870558     102.4089          
Saline  3370950     89.19004          
Saline  4461750     118.0509          
                    
                    
      3779514     100  17.07933  7.638109 
                    
Insulin  3198798     84.63517          
Insulin  2743524     72.58933          
Insulin  2197800     58.15033          
Insulin  4339980     114.829          
                    
                    
            82.55097  24.08903  10.77294 
            0.213436       
      3120026             
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  11894800     89.78454          
Saline  14740972     111.2681          
Saline  12312166     92.93491          
Saline  13194910     99.59805          
Saline  12726912     96.0655          
Saline  14619207     110.349          
                    
                    
      13248161     100  8.988694  4.019866 
                    
Insulin  10467293     79.0094          
Insulin  13454355     101.5564          
Insulin  14471112     109.2311          
Insulin  14956270     112.8932          
                    
                    
            100.6725  15.19502  6.795418 
            0.93128       
      13337257             
 













      Avgavg  %Control  Avg  Stdev  SEM  
Saline  11443848     89.99145          
Saline  12383162     97.37797          
Saline  13562415     106.6513          
Saline  13098983     103.007          
Saline  11714813     92.12225          
Saline  14096346     110.85          
                    
                    
      12716594     100  8.247542  3.688413 
                    
Insulin  13490304     106.0843          
Insulin  14309196     112.5238          
Insulin  13468374     105.9118          
Insulin  13132910     103.2738          
                    
                    
            106.9484  3.933157  1.758961 
            0.16006       
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  3576617     79.67763          
Saline  4917862     109.557          
Saline  5299308     118.0546          
Saline  4936665     109.9759          
Saline  3713848     82.73477          
                    
                    
                    
      4488860     100  17.52079  7.835537 
                    
Insulin  3056851     68.0986          
Insulin  3784426     84.30705          
Insulin  4217537     93.95564          
Insulin  4188489     93.30852          
Insulin  3804264     84.74899          
                    
            84.88376  10.43274  4.665662 
            0.135989       
      3810313             
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  5763713     61.80467          
Saline  7277970     78.04216          
Saline  7153230     76.70456          
Saline  15336458     164.4539          
Saline  11097083     118.9948          
                    
                    
                    
      9325691     100  41.82944  18.70669 
                    
Insulin  6867315     73.63868          
Insulin  5734365     61.48998          
Insulin  5489925     58.86883          
Insulin  5540168     59.40758          
Insulin  9006638     96.57877          
                    
            69.99677  16.03273  7.170055 
            0.172604       
      6527682             
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  13504150     99.19009          
Saline  14241480     104.6059          
Saline  14251655     104.6806          
Saline  13492985     99.10809          
Saline  12581800     92.41529          
                    
                    
                    
      13614414     100  5.052275  2.259446 
                    
Insulin  10953415     80.45455          
Insulin  12953435     95.14501          
Insulin  12673925     93.09196          
Insulin  12811645     94.10354          
Insulin  12907620     94.80849          
                    
            91.52071  6.23588  2.78877 
            0.045783       
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  11498630     96.97308          
Saline  12995070     109.5932          
Saline  11663685     98.36506          
Saline  11108955     93.68677          
Saline  12021405     101.3819          
                    
                    
                    
      11857549     100  6.033896  2.69844 
                    
Insulin  10442410     88.0655          
Insulin  10786490     90.96728          
Insulin  11016390     92.90613          
Insulin  11841335     99.86326          
Insulin  10406550     87.76308          
                    
            91.91305  4.927282  2.203547 
            0.048823       
 













      Avgavg  %Control  Avg  Stdev  SEM  
Saline  3165812     71.47964          
Saline  2532140     57.17221          
Saline  6247748     141.0655          
Saline  5770180     130.2827          
                    
                    
                    
                    
      4428970     100  41.83716  18.71015 
                    
Insulin  3746132     84.58246          
Insulin  6198348     139.9501          
Insulin  3239496     73.14333          
Insulin  6608784     149.2172          
Insulin  4726176     106.7105          
Insulin  4369144     98.64921          
            108.7088  30.22952  13.51905 
            0.710215       
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  4838575.5     65.80895          
Saline  3711708     50.48255          
Saline  10406583     141.5388          
Saline  10452964.5     142.1697          
                    
                    
                    
                    
      7352458     100  48.73315  21.79413 
                    
Insulin  4959108     67.4483          
Insulin  7801992     106.1141          
Insulin  4714132.5     64.11642          
Insulin  7797240     106.0494          
Insulin  7065580.5     96.09821          
Insulin  6040237.5     82.15263          
            86.99651  18.65706  8.343693 
            0.561845       
 













   Average  Avgavg  %Control  Avg  Stdev  SEM  
Saline  11194345     98.95899          
Saline  10410351     92.02841          
Saline  12108120     107.0368          
Saline  11535605     101.9758          
                    
                    
                    
                    
      11312105     100  6.272973  2.805359 
                    
Insulin  10185199     90.03805          
Insulin  11704258     103.4667          
Insulin  10854385     95.95371          
Insulin  12125183     107.1877          
Insulin  10949926     96.7983          
Insulin  12090887     106.8845          
            100.0548  6.883641  3.078458 
            0.990141       
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